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Cre recombinase recombines its DNA target, loxP sites, without help of accessory proteins or 
DNA repair systems. The simplicity of Cre-lox system has been widely utilized for genome 
editing, especially in mouse genetics. The goal of this dissertation is to 
construct Cre recombinase variants that will operate upon recombination target sites (RTs) 
present within the genome, instead of perturbing the genome by inserting wild-type RTs for 
subsequent genome engineering. In general, the desired RTs native to the genome are 
asymmetric. However, the loxP sequence is pseudo-palindromic, requiring a homotetrameric 
formation of Cre recombinase. As a first step, I broke the symmetry of Cre tetramer so that each 
Cre monomer could be arranged spatially to bind distinct RT half-sites. I designed an alternative 
protein-protein interface for Cre. Then, I separated the mutations into a pair of Cre monomers. I 
could then arrange the assembly of this pair of complementary Cre monomers to form a 
functional heterotetramer, even though neither monomer exhibits activity alone. When combined 
with other mutations that confer distinct DNA specificities, the monomers preferentially formed 
the desired complex and recombined asymmetric DNA sequences with greater fidelity. I’ve 
successfully found a pair of Cre monomers that do not work in isolation, but do when combined 
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together. This has been successfully demonstrated in vivo in E. coli, mouse ES cell cultures and 
mouse retinal explants. As the next step, I need to change the DNA specificity of Cre 
recombinase to recognize native genomic sites. Surprisingly, the DNA preferences of Cre 
recombinase have not been thoroughly characterized. The 34 bp RT site loxP contains two 
palindromic arm regions and an 8 bp spacer region. The arm region is recognized by Cre 
monomers while homology of the spacer region determines compatibility between RT sites. 
While the consensus sequence of loxP is known, I performed the first high-throughput studies to 
determine Cre’s sequence specificity in the arm region. I broke the 13 bp arm region into 3 
overlapping 5-6 bp small windows and used in vitro recombination and high-throughput 
sequencing data to generate logos for each window. I found that non-specific recombination can 
interfere with the analysis and careful selection of NaCl concentration is important for observing 
in vitro specificity. I have not only determined Cre’s sequence preferences, but also used similar 
methods to determine CreC2#4 (a Cre mutant) and VCre (a Cre homolog). In contrast to zinc 
finger and TAL effector domains, no modular decomposition of DNA specificity exists for Cre 
recombinase homologs. As a result, the RT specificity of Cre has previously been modified using 
directed evolution, a laborious approach. To accelerate the process, I used sequence information 
from homologs of Cre.  By searching across genomes of different bacteria species, I found 
hundreds of Cre homologs. Closely related homologs share similarity in both amino acid 
sequence and predicted RT DNA sequence. By comparing residues that differ between close 
homologs in the aligned regions where Cre contacts the switched base pairs, I found candidate 
possible mutations for a specificity switch. The change in specificity was validated by the high-
throughput sequencing assay. This demonstrates the feasibility of leveraging sequence alignment 
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data to alter the specificity of Cre recombinase, reducing the amount of effort needed to generate 
mutants with novel RT preferences.
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Chapter 1 
Introduction: 
Directed Evolution, Cre Recombinase and RMCE 
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Directed evolution of enzymes 
Directed evolution is a method used in enzyme engineering that utilizes features of 
natural selection to evolve proteins to achieve a specific goal. It consists of two iterative steps: 
variant library creation/amplification and selection (1). It has proved to be a powerful and 
broadly applicable tool for altering the activities of enzymes. Strategies for directed evolution 
usually focus on both sequence diversifications for library construction and selection for altered 
activity.  
The mutational sequence space of a full length protein is huge. Complete randomization 
of ten amino acids yields 1013 unique combinations. However, in vivo bacterial selections are 
limited by the transformation efficiency (at best 109 - 1011). Since exhaustive coverage of 
mutational space is impossible to achieve, directed evolution samples only a fraction of this large 
sequence space, with beneficial mutations accumulated successively in each round. Goeddel and 
co-workers first employed error-prone PCR to create random mutagenesis in vitro (2). By 
altering PCR conditions or using a proprietary mixtures of polymerases, mutation rates of 10-4 to 
10-3 per base are achievable, and biases for different modes of mutation (e.g. transitions versus 
transversions) can be reduced (3) (4). When specific residues responsible for binding or catalysis 
are known, a more targeted strategy may be used. Synthetic DNA oligonucleotides containing 
degenerate codons targeted to the residues of interest can achieve exhaustive mutation of 
important residues (5). After several rounds of accumulating beneficial mutations, the technique 
of DNA shuffling can be applied to access combinations of these mutations. In this approach, 
first described by Stemmer, a family of genes is treated with DNase. Fragments of a desired 
length are then gel purified, and used as primers to reassemble a chimeric gene in a PCR reaction 
(6). To provide greater control over fragment size, recent protocols leverage misincorporation of 
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dUTP during PCR. Fragments of the amplicons are generated by treatment with uracil 
deglycosylases and apurinic/apyrimidinic lyases, and the size of the fragments can be controlled 
by the rate of dUTP misincorporation (7). 
Effective selection strategies often link the desired enzymatic activity to the physical 
separation of the encoding DNA of the desired subpopulations of variants or to the survival of 
the organism expressing the enzyme. In binding affinity selections, protein library members are 
captured by an immobilized target together with their encoding DNA sequences. Phage display 
methods have broad applications in protein engineering and can serve as a successful example, 
where the protein library of interest is fused with phage coat proteins and expressed on the 
surface of the phage (8) (9). While non-binding phages are washed away, the bound phages then 
serve as the compartment to segregate the protein with the encoding DNA. The other strategy is 
to link the function of the enzyme to fitness survival of the organism. The most common practice 
is to evolve proteins by linking their activity to the expression of an antibiotic resistance gene. 
For example, Barbas and colleagues altered serine recombinases’ DNA specificities by using the 
recombinase activity to reassemble a beta-lactamase gene (10). In the above strategies, cells or 
phages were used as compartments, where the library size was limited by the transformation 
efficiency. Purely in vitro selections, utilizing cell-free translation reactions, can bypass this 
limitation. One straight forward approach is to use mRNA display or ribosome display, where 
the mRNA is linked to the protein during translation (11) (12). In another in vitro approach, the 
encoding DNA and proteins are trapped in aqueous droplets of water-oil emulsions. This 
approach is particularly useful to evolve enzymes that directly operate on DNA. Reported 
examples include nucleases, RNA and DNA polymerases or enzymes with activities that can be 
linked to a polymerase (13) (14) (15). 
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The Cre-lox system 
Cre recombinase is a 380 kDa protein originated from bacteriophage P1. It belongs to the 
λ integrase family, other examples of which include λ intergrase, Flp and more recently Vika, 
Scre, and VCre (16)-19). Cre recombines a specific 34 bp DNA recombination target (RT) site, 
the loxP sequence. LoxP site contains two palindromic 13 bp arm regions and an asymmetric 8 
bp spacer region (Figure 1.1)(17). Each arm region is recognized by a Cre monomer. While there 
is no direct contact between Cre and the spacer region, the homology of the spacer is required for 
efficient recombination between two RT sites (18).  
The recombination synaptic complex contains four Cre monomers, forming a 
homotetramer, and two loxP DNA sequances in an anti-parallel arrangement (Figure 1.2)(19). 
Cre cleaves and religates after position 14 of the top loxP strand and before position -14 of the 
bottom strand (Figure 1.1). During cleavage, residue Y324 is covalently linked to the 5’ 
phosphate of the cleaved nucleotide. The four-fold protein symmetry imposes a pseudo-
palindromic symmetry requirement on the RT site.  
Altering Cre’s DNA specificities 
Several high resolution Cre-DNA crystals structures are available and can serve as a 
guide to rational redesign of DNA specificity. The protein-DNA interface is complex, with both 
direct interactions between the protein side chains and the DNA bases, and indirect interactions 
mediated by water molecules. In contrast to zinc finger or TAL effector domains, there is no 
modular decomposition for the interface. The absence of any simple scheme for understanding 
Cre’s specificity for DNA makes the selection of specificity-altering mutations a significant 
challenge. 
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There have been several attempts to characterize the DNA sequence specificity of 
wil-type Cre recombinase. A sequencing study has been published for the specificity and 
compatibility of the loxP spacer region (20), but the specificity in the arm region was not 
characterized. In another study, a randomized library approach to identifying alternative lox sites 
showed some of Cre’s sequence preferences in vivo (21). Because of extreme sequence 
promiscuity observed using their experimental conditions, they were unable to obtain detailed 
sequence preferences. Before attempting to change Cre’s DNA specificity, it is important to fully 
characterize the protein-DNA interaction.  One promising approach is to couple a functional 
screen for recombinase activity against a randomized library with the massive throughput 
capabilities of next-generation sequencing. With a detailed position weight matrix for Cre 
specificity in hand, we can improve our ability to find candidate target site in the genome by 
taking into account which mismatches with the loxP sequence have the most effect on Cre’s 
recombinase activity. 
Directed evolution is a powerful tool for altering Cre’s DNA specificity. Buchholz and 
Stewart retargeted Cre to recombine a site from human chromosome 22, which they called the 
loxH site (22). In their approach, full length Cre recombinase was randomized by error-prone 
PCR. The loxH site has four changes in the arm region and a different spacer region. They used 
both positive and negative selection steps in vivo in bacterial cells. First, Cre mutants were 
evolved to recombine a loxP/loxH hybrid site for ten rounds. Then, Cre mutants were evolved 
for another ten rounds to efficiently recombine the full loxH site. However, the resulting mutants 
were still able to recombine loxP sites with significant activity. Therefore, they performed fifteen 
additional rounds of negative selection to evolve Cre against loxP sites, while retaining the 
ability to recombine loxH site. From the mutant library, a single clone (called Fre22) were 
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selected as the most specific mutant, with little activity for loxP and moderate activity for loxH. 
In a separate effort, Santoro and Schultz retargeted Cre to recombine loxM7 sites, which contain 
three changes from the loxP site (23). They used a focused mutational approach in which only 
five residues in the Cre protein (identified from the crystal structure) were randomized. They 
used GFP and RFP as reporter genes, and FACS sorting to separate functional clones. They also 
directly compared directed evolution using only positive selection with an approach that 
alternated rounds of positive and negative selection. They performed three rounds of positive 
selection alone on two libraries and five alternating rounds positive/negative selection on another 
two libraries. Mutants obtained from just positive selection were generally promiscuous in 
recombining both loxP and loxM7 sites, while mutants coming from alternating rounds of 
positive and negative selection exhibited much better specificity. A clone (named CreC2#4) was 
chosen as the most specific recombinase for loxM7 site. In a more recent approach, Buchholz 
and colleagues applied directed evolution to evolve Cre to target a sequence in the long-terminal 
repeat of the HIV-1 strain (named loxLTR) (24). This site has four changes in the left arm region, 
seven changes on the right, and has a different spacer region. The full length Cre sequence was 
randomized by error-prone PCR. They used an iterative positive selection strategy, sequentially 
targeting intermediate half-sites, separate symmetric half-sites, and the asymmetric full site. 
Surprisingly, although the two half sites have different sequences, they were able to obtain a Cre 
mutant that could recombine the asymmetric RT site after 126 rounds of directed evolution. The 
final Cre mutant, called Tre, successfully recombined the loxLTR sites in vivo, resulting in 
excision of the proviral HIV genome in cultured HeLa cells. 
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Symmetry of Cre recombinase tetramer 
After directed evolution, Cre variants with altered DNA specificity that could target 
distinct RT sites can be obtained. However, the tetrameric formation of Cre complex puts a 
symmetric requirement on the RT sites they recombine, and the variants could only have limited 
use if only pseudo-palindromic sites are considered. Cre mutants with specificities towards the 
two half-sites of asymmetric RT site can be used to recombine these sites, but any combination 
of the two half-sites in the genome will be recombined, generating off-target recombination. 
Carmi and colleagues used a mixture of wild-type Cre and a Cre variant (CreC2#4) that 
recombines loxM7 site to recombine chimeric asymmetric sites containing both loxP and loxM7 
half-sites (25). Their study not only demonstrated the promiscuity of mixture, it also showed 
application of wild type Cre or CreC2#4 alone could recombine these chimeric sites. Thus, by 
controlling the tetramer assembly, constructing separately mutatable Cre monomers that will 
function as obligate heterotetramer, but will be inactive in isolation is an attractive strategy for 
enhancing the specificity for RT site recognition. To address this issue, Baldwin and colleagues 
used a reciprocal small-to-large substitutions approach to create an alternative binding interface 
for Cre monomers (26). The redesigned pair of Cre monomers showed increased fidelity to 
recombine asymmetric sites, but one of the monomers showed reduced but clear activity in 
isolation. A pair of completely “orthogonal” Cre monomer is desirable for genomic applications. 
Recombination mediated cassette exchange (RMCE) 
There are several applications for Cre recombinase in genome editing. Recombination 
between two DNA molecules can drive either an insertion or a translocation event (Figure 2.1A).  
Recombination within one molecule generates either a deletion or an inversion event, depending 
on the relative orientations of the loxP sites (Figure 2.1B). One of the most common applications 
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of Cre recombinase is to generate conditional gene knockouts. By placing the expression of Cre 
recombinase under the control of promoters that are specific for particular developmental stages 
or tissues, a gene of interest that is flanked by loxP sites (floxed) can be excised from the 
genome (Figure 2.1A).  
Insertional integration using native loxP sites is difficult because the final product 
contains two direct-repeat loxP sites, and is therefore susceptible to excision in the presence of 
the recombinases required to accomplish the integration (Figure 2.1A). One solution, first 
described in plants, is to utilize pairs of mutant RT sites (27). The crucial property for such a pair 
of sites is that each harbors a suboptimal half-site sequence on the left and right flanks, 
respectively. After recombination, one of the resulting RT sites contains both suboptimal 
half-sites, yielding a nonfunctional RT. Using this approach, the lox66/lox71 pair of mutant RT 
sites was later used to integrate into mouse embryonic stem cells (28). For the mutant RT sites, 
16% of the insertions were targeted in their best conditions, while for wild type lox, the number 
was < 0.5%. This also implies that 84% of the insertions were random. The next advance came 
from Sauer and colleagues, which they called the method double-lox replacement, or 
reciprocal/segmental replacement, which was later named RMCE (29). The DNA fragment of 
interest (cassette) was flanked by incompatible heterologous RT sites. The idea leveraged off of 
the observation that lox site variants that differed in their spacer regions could not recombine 
with each other. By using heterologous lox sites, double crossovers could be accomplished with 
Cre that exchanged similarly bounded genetic intervals between different DNA molecules 
(Figure 1.3). They tested the introduction of a cassette harboring a selectable marker.  Of the 
clones that become resistant to the selective drug, 75% had the insertion at the correct genome 
locus. This compares well to the 16% for the previous single integration effort. They also 
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analyzed the efficiency when no selectable markers were used. Cytometry indicated that 10% of 
the cells took up DNA. 96 of cells that took up DNA were analyzed, and two had the correct 
integration. Another group also reported results using double recombinations, introducing the 
term RMCE (30). When they tried RMCE without selection, ~1% of the cells that survived 
transfection had undergone RMCE. They got efficiencies of 4% and 16% for two different loci if 
only cells that took up DNA (as determined by cotransfection with a fluorescent reporter) were 
considered. When additional drug selection was performed, they got efficiencies of 10% and 
50%.  
This RMCE approach has several advantages over traditional Cre-mediated insertion. 
First, unlike Cre-mediated insertion, the recombination product is not susceptible to excision. 
Additional exogenous template vectors are added to push the reaction equilibrium towards gene 
conversion, so the efficiency of genome modification is higher with RMCE. Second, less 
cytotoxicity can be achieved because less Cre protein is required than for insertional integration. 
Third, the exchange boundaries are better defined in RMCE, making the integration more precise 
than Cre-mediated insertion. 
Advantages of RMCE over double-stranded break (DSB) stimulated 
homology-directed repair (HDR) 
DSB inducing agents, such as TALEN effectors, CRISPR/Cas, and zinc-finger nucleases 
(ZFNs) have emerged as attractive tools for genome engineering. The modular DNA binding 
domain of TALENs and ZFNs makes it easy to change their DNA specificities (31) (32). The 
Cas9 nuclease can be targeted to any site with a protospacer adjacent motif (PAM) sequence 
without the need to change the protein sequence (33). Loss of function mutants are generated 
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when the DSB is repaired by non-homologous end-joing (NHEJ) and gene conversion mutants 
are generated by HDR, when repair templates are exogenously provided (34). 
DSB is efficient in generating local mutations or loss-of-function mutants, but not very 
efficient to operate on whole gene replacement. DSB stimulated gene conversion efficiency is 
highest close to the cleavage site. Efficiency for incorporation of altered bases falls to 25% of its 
peak value at distances of only 100 bp (35).  As an example, IL2Rγ is a target locus for gene 
therapy that causes X linked SCID (http://genome.nhgri.nih.gov/scid/index.shtml) (36).  The 
cDNA is over 1 kb, and the gene itself is over 4 kb. Efficient targeting of all mutations for this 
locus would require dozens of double strand inducers. Each must be characterized and subjected 
to rigorous testing before application as a therapy. In contrast, 4 kbp is well within the efficient 
distance scale for Cre recombinase (30, 37, 38). Thus, a single combination of locus bracketing 
recombinases can be studied thoroughly and applied to all of the mutations, justifying the greater 
effort required to engineer a novel Cre recombinase compared to the inherently modular ZFNs, 
TALENs and CRESPER/Cas systems.  
There are several other advantages of RMCE over DSB-induced HDR for genome 
modification. First, RMCE does not depend on the host cell’s relative preference for HDR over 
NHEJ. Second, illegitimate integrations generated by undesired RMCE modifications can be 
identified by rapid inverse PCR techniques, while NHEJ healed DSBs can be difficult to identify. 
Finally, different technologies for genome modification (ZFNs, TALENs and RMCE) have been 
developed to different stages of maturity. Until all of these technologies are fully characterized 
and the relative merits determined, it is important to pursue all reasonable approaches. 
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Focus of the dissertation 
The ultimate goal of this research is to engineer Cre recombinase to operate upon native 
genomic sequences. Chapter 2 describes a method to recombine asymmetric sites. Chapter 3 
describes a method called ‘Rec-Seq’ to characterize DNA specificities of recombinases, and also 
discusses using bioinformatics to accelerate retargeting of recombinases.  
The quaternary structure of the Cre complex creates a challenge for retargeting genomic 
RT sites. The four-fold symmetry of the synaptic complex imposes a pseudo-palindromic 
symmetry upon the RT site. In chapter 2, I redesigned the monomer-monomer interface for Cre 
recombinase using a combination of computational and rational design. I then assembled the 
complex to form an obligate heterotetramer. When combined with mutants with distinct DNA 
specificities, the heterotetramer recombined asymmetric sites with greater fidelity. The 
‘orthogonal’ pair of Cre monomers were validated in both mammalian cell cultures and tissues. 
As many recombinases originate from bacteriophages, the preferred RT sequence of 
some recombinases can be identified in the bacterial genome close to the encoding gene (39). 
However, just identifying the preferred RT sequence is not enough to fully characterize the DNA 
specificity of a recombinase. It is important to know the relative binding preferences for other 
sequences existing in the genome. In recent studies, the DNA binding specificities of 
transcription factors (TFs) have been determined via high-throughput sequencing of the bound 
subset of randomized DNA binding sites (40). In contrast to TFs, tyrosine recombinases exhibit 
their specificity in an enzymatic reaction in which two RT sites are cleaved and religated, 
making it a more challenging problem. In chapter 3, I have established a method called ‘Rec-Seq’ 
that utilizes recombination rather than binding as an enrichment method to characterize the DNA 
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specificity of recombinases. By analyzing the sequence alignment of Cre homologs, I have also 
managed to change the DNA specificity of Cre recombinase, using Rec-Seq as the confirmatory 
technology for the altered specificity. 
Finally, chapter 4 concludes this dissertation and proposes future research in engineering 
recombinases.  
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Figure 1.1 34 bp loxP DNA sequence 
The pseudo-palindromic 34 bp loxP DNA sequence contains two symmetrical 13 bp arm 
(colored in grey) region and an asymmetrical 8 bp spacer region (colored in green). The blue 
arrows indicate the cleavage point introduced by Cre recombinase. 
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Figure 1.2 Synaptic complex of Cre homotetramer 
A structural view of the Cre tetramer in complex of two loxP DNA sequence taken from PDB 
structure 1KBU. Cre monomers are colored in cyan and DNA is colored in orange. 
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Figure 1.3 Schemes of RMCE 
RMCE utilizes two incompatible RT sites (colored in orange and green) to define the boundaries 
of the cassette of interest in the genome (colored in blue) and replace it with the exogenously 
provided template (colored in yellow). Unlike traditional Cre induced integration, the resulting 
exchange product is not susceptible to excision. 
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Chapter 2 
 Redesign of the Monomer-monomer Interface of Cre Recombinase Yields an Obligate 
Heterotetrameric Complex 
This Chapter has been published: 
Zhang, C, CA Myers, Z Qi, RD Mitra, JC Corbo, and JJ Havranek. 2015. Redesign of the 
monomer-monomer interface of Cre recombinase yields an obligate heterotetrameric complex. 
Nucleic Acids Res 43, no. 18: 9076-9085. 
The author contributions are the following: James Havranek and Chi Zhang did the protein 
design. Chi Zhang cloned, purified and tested the mutants in vitro. Connie Myers and Joseph 
Corbo designed and performed the mouse retinal explant assay. Zongtai Qi and Robi Mitra 
designed and performed the mouse ES cell culture assay. The manuscript was written and 
revised primarily by Chi Zhang and James Havranek. 
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ABSTRACT 
Cre recombinase catalyzes the cleavage and religation of DNA at loxP sites. The enzyme is a 
homotetramer in its functional state, and the symmetry of the protein complex enforces a 
pseudo-palindromic symmetry upon the loxP sequence. The Cre-lox system is a powerful tool 
for many researchers, particularly those working in mouse genetics.  However, broader 
application of the system is limited by the fixed sequence preferences of Cre, which are 
determined by both the direct DNA contacts and the homotetrameric arrangement of the Cre 
monomers. As a first step towards achieving recombination at arbitrary asymmetric target sites, 
we have broken the symmetry of the Cre tetramer assembly. Using a combination of 
computational and rational protein design, we have engineered an alternative interface between 
Cre monomers that is functional yet incompatible with the wild-type interface. Wild-type and 
engineered interface halves can be mixed to create two distinct Cre mutants, neither of which are 
functional in isolation, but which can form an active heterotetramer when combined. When these 
distinct mutants possess different DNA specificities, control over complex assembly directly 
discourages recombination at unwanted half-site combinations, enhancing the specificity of 
asymmetric site recombination. The engineered Cre mutants exhibit this assembly pattern in a 
variety of contexts, including mammalian cells. The availability of obligate heterotetrameric 
mutants opens the door to the controlled assembly of Cre monomers whose DNA specificities 
may be altered independently. 
INTRODUCTION 
Cre recombinase forms a tetrameric complex that splices DNA molecules containing the 
34-bp recombination target (RT) site loxP (1), recombining two DNA molecules in trans to 
accomplish an insertion or translocation event, or in cis to achieve either gene excision or 
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inversion, depending on the relative orientation of the loxP sites (Figure 2.1). Cre recombinase 
has been used to generate conditional gene knockouts, where a gene of interest is flanked by 
loxP sites (‘floxed’) (2). Expression of Cre recombinase under the control of promoters that are 
specific for particular tissues or developmental stages abrogates gene function by physical 
excision from the genome. The utility of this system depends on the functional autonomy of Cre 
recombinase: the enzyme requires no other factors to splice DNA, and is capable of modifying 
genomes in non-replicating cells, where the efficacy of gene conversion via double-strand break 
(DSB) induced homologous recombination is expected to be low (3, 4). 
Another application for Cre recombinase is recombination-mediated cassette exchange 
(RMCE) (5), also known as double-reciprocal crossover (6, 7) or double-lox replacement (8, 9). 
In this approach, (reviewed in ref. (10)) recombination between DNA molecules that share two 
neighboring heterologous RT sites accomplishes the exchange of the bounded genetic interval 
(the cassette) between the sites (Figure 2.1C). This has been demonstrated using both Flp and 
Cre recombinase with heterologous RT variants (5, 8), as well as simultaneously with Cre and 
the Flp recombinases (11). Although RMCE has so far only been demonstrated with wild-type 
recombinase proteins and RT sites, the approach has many attractive features as a tool for 
genome engineering. First, it has a higher efficiency for gene conversion than does Cre-mediated 
insertion, as it does not require survival of insertional events that are susceptible to reversal by 
excision (8). Second, the cassettes that are exchanged are precisely demarcated, yielding truly 
‘scarless’ genomic surgery. Third, the process requires less Cre protein than recombinational 
insertion, resulting in less cytotoxicity(8). Finally, the autonomy of Cre as a recombinase 
suggests that RMCE could prove to be effective in terminally differentiated cells, in contrast to 
strategies for gene conversion that rely upon homology directed repair. 
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One impediment to broader use of Cre recombinase is the inflexibility of the binding site 
specificity. In contrast to DNA binding proteins whose specificity derives from the assembly of 
small recognition modules such as zinc finger or TAL effector domains, Cre recombinase 
interacts with DNA through large interfaces that defy a modular decomposition. Nevertheless, 
altered RT specificities have been elicited in mutant Cre recombinases using directed evolution 
(12-14). 
The quaternary structure of the Cre complex creates a second challenge for engineering 
novel RT specificities. The four-fold symmetry in the functional protein complex imposes a 
pseudo-palindromic symmetry upon the RT site. The loxP site consists of two 13 bp palindromic 
half-sites separated by an asymmetric 8 bp spacer that gives loxP its direction. The utility of 
targeting Cre mutants to altered RT sites is severely compromised if only pseudo-palindromic 
sites may be considered. This limitation has been addressed by using directed evolution to 
generate mutant homotetrameric complexes that can operate on asymmetric sites (14, 15). 
However, requiring a single Cre mutant to operate on two different half-sites is likely to result in 
promiscuous enzymes. Separate Cre mutants with specificities towards the two half-sites of an 
asymmetric RT site may be able to recombine these sites, but the lack of control over assembly 
of the complex allows for any combination of these half-sites as potential sites for recombination 
(16). Some of these combinations will be undesired, generating off-target recombination events 
and exacerbating the cytotoxicity of Cre recombinase (17). 
 A similar technical challenge has been overcome in the design of zinc finger nucleases 
(ZFNs). ZFNs are DSB agents that achieve their sequence specificity by concatenating multiple 
zinc finger modules, each of which recognizes 3-4 base pairs. The cleavage activity is provided 
by the dimeric FokI nuclease. FokI monomers are genetically fused to zinc finger arrays, and two 
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such constructs that converge upon a DNA site reconstitute a functional nuclease dimer, inducing 
a DSB. The development of obligate heterodimer FokI mutants has increased target specificity 
and reduced cytotoxicity in this system (18). Under this approach, the ZFNs that co-locate on 
desired cleavage sites must contribute two distinct FokI monomers; misassembly of two copies 
of the same ZFN at an off-target site cannot reconstitute a functional nuclease. Constructing a 
functional Cre complex from distinguishable and separately mutatable monomers is an attractive 
strategy for enhancing the specificity of RT site recognition. An earlier effort to generate 
heterotetramer Cre mutants succeeded in forming a novel functional interface, but one of the two 
mutants retained significant activity as a homotetramer (19). 
In this manuscript we describe the engineering of Cre mutants that are inactive in 
isolation, but are functional as a (ABAB) heterotetramer when both mutants are present. We use 
a combination of computational and rational design to select mutations that are predicted to form 
a novel interface between Cre monomers that is functional, but whose halves are incompatible 
with their wild-type counterparts. We show that the negative engineering goal (incompatibility 
with wild-type) is more difficult to achieve than the positive goal (full functionality), requiring 
three iterations of mutation. The obligate heterotetrameric assembly of the pair of mutants is 
demonstrated in vitro and in vivo, notably in mammalian cells. We hope that the availability of 
these mutants enables the specific and reliable targeting of Cre to asymmetric RT sites. 
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MATERIALS AND METHODS 
Computational modeling and design 
We selected the 2.2 Å crystal structure of a Cre-loxP Holliday junction as a template for 
computational design (PDB code: 1KBU (20)). The protein design capabilities of Rosetta3 (21) 
were used to select amino acids to form an alternative interface between Cre monomers. Amino 
acid positions 25, 29, 32, 33, 35 from chain A and 69, 72, 76, 119, 123 from chain B were 
chosen by eye for redesign because they form multiple interactions across the largest region of 
contact between monomers, but do not participate in the protein-DNA interface (Figure 2.2). At 
each of these positions, the calculation permitted mutation to a subset of amino acids including 
positive, negative or non-polar amino acids (AVMLDERK). The redesign calculation used the 
standard RosettaDesign fixed backbone algorithm. Sidechain rotamers were built using a 
backbone-dependent rotamer library (22). Extra rotamers sampling additional values for the  χ1 
and χ2 side chain torsion angles were included in the design calculation (command line options –
ex1, -ex2 in Rosetta). A scoring function using a softened form of the Lennard-Jones potential 
(soft_rep_design) was used (23) to evaluate the interactions between the rotamers and the fixed 
backbone, and between rotamers at different positions. The combinatorial search through 
conformational space was accomplished using a Monte Carlo method with Metropolis 
acceptance criteria. 
Gene construction and protein expression 
A gene encoding wild-type Cre recombinase with an N-terminal Met-His7 tag was 
constructed from 100bp overlapping oligonucleotides ordered from Integrated DNA technologies 
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(IDT) and cloned into the pET42a vector. Cre mutants were generated by site-directed 
mutagenesis. Proteins were expressed in BL21(DE3) star cells at 30°C using the autoinduction 
protocol of Studier (24). Details of the purification strategy are given in the Supplemental 
Materials.  
In vitro recombinase activity assay 
Two direct loxP repeats or other variants of loxP/M7 sites separated by a ~0.5 kb spacer 
were cloned between the XbaI and SphI sites of the pBAD33 plasmid. The 0.7 kb DNA substrate 
for in vitro recombination assays was generated by PCR amplification with pBAD-forward and 
pBAD-reverse primers. 1µg of the DNA substrate was incubated with 1 µM Cre in 10 µL of 
50 mM Tris-HCl, pH 7.8, 50 mM NaCl and 10 mM MgCl2 for 12 hours at 37° C. Total amount 
of protein used is the same across all in vitro assays. Reactions were stopped by incubation at 
98° C for 20 minutes. Reactions were analyzed on 2% agarose gels and visualized by staining 
with GelGreen nucleic acid stain (Biotium). 
Cell culture and transfection 
The plasmid pGL4.23 (GenBank accession number: DQ904455) containing a multiple 
cloning site (MCS) for insertion of a response element of interest upstream of a minimal 
promoter and a gene encoding luc2 was purchased from Promega. The original minimal 
promoter in pGL4.23 was replaced with the haemoglobin beta (HBB) gene minimal promoter 
144bp upstream of the HBB transcription start site. The HBB minimal promoter has only the 
basic components for transcription (i.e. TATA box and GC box) and was amplified by PCR from 
mouse genomic DNA. The coding sequence of luc2 in PGL4.23 gene was replaced with different 
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mutants of Cre recombinase using Gibson assembly. The enhancer candidates (CMV and SP1 
enhancers) were then cloned into the MCS upstream of the minimal promoter. The engineered 
plasmids were isolated using standard molecular biology techniques and were confirmed by 
Sanger sequencing. 
Ai14 mouse embryonic stem (ES) cells were engineered by targeted insertion of a 
construct containing the CAG promoter, followed by a floxed stop cassette-controlled red 
fluorescent marker gene (tdTomato) (Figure 2.4A) (25). The Ai14 mouse ES cells were cultured 
in complete media consisting of Dulbecco's modified eagle media (DMEM; Gibco) 
supplemented with 10% new born calf serum, 10% fetal bovine serum (FBS; Gibco), and 0.3 
mM of each of the following nucleosides: adenosine, guanosine, cytosine, thymidine, and uridine 
(Sigma-Aldrich). To maintain their undifferentiated state, the cells were also cultured in flasks 
coated with a 0.1% gelatin solution (Sigma-Aldrich) in the presence of 1000 U/mL leukemia 
inhibitory factor (LIF; Chemicon) and 20 mM β-mercaptoethanol (BME; Invitrogen).  
Plasmids used for transfection of cells were prepared using EndoFree Plasmid Maxi Kits 
(Qiagen). About 2 x 105 Ai14 ESCs were plated in one well of a six-well plate one day prior to 
transfection with complete medium plus LIF in feeder free conditions. The cells were then 
transfected at 70% confluence by Lipofectamine 2000 (Invitrogen). For each transfection 
experiment, a total of 1 μg of plasmid DNA and 8 μL of Lipofectamine 2000 reagent were mixed 
following the manufacturer’s protocol, and incubated at room temperature for 5 minutes before 
adding to the culture medium. The medium was replaced with fresh ESC medium plus LIF the 
following day and cells were cultured for another day before harvested for fluorescence activated 
cell sorting (FACS). 
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Flow cytometry 
Upon reaching approximately 100% confluence, the cells were trypsinized from the plate 
and were suspended in Hank’s Balanced Salt Solution (HBSS) supplemented with 2 mM EDTA, 
washed once with PBS, and resuspended in 500 μl PBS. Cellular fluorescence was analyzed on 
an iCyt Reflection HAPS2 cell sorter at the Washington University Siteman Flow Cytometry 
Core. Cells were treated with propidium iodide (2 µg/ml) prior to sorting to counter-select dead 
cells. The gate was set relative to cells transfected with plasmids lacking red fluorescent protein 
genes (negative controls) to eliminate nonspecific background reporting. A minimum of 7000 
total live single cells was analyzed from each FACS and post-sort analysis was performed with 
FlowJo software to obtain the percentage of RFP positive cells. 
Recombinase assay in mouse retinal explants  
Electroporations and explant cultures were performed as previously described (26). 
Retinal explants were electroporated in a chamber containing 0.5 µg/mL each of supercoiled 
DNA encoding a gene for Nrl-eGFP as a control for electroporation efficiency, a reporter 
construct for Cre activity comprised of DsRed preceded by a floxed stop codon, and a gene 
encoding either wild-type or engineered Cre under control of the Nrl promoter (27). Three 
replicates were performed for each electroporation. Quantification of fluorescence in retinal 
explants was accomplished using the ImageJ program (http://rsbweb.nih.gov/ij/) using a 
previously described protocol (28). 
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RESULTS 
Computational redesign of a non-native but functional protein-protein interface between 
Cre recombinase monomers 
We desired an engineered protein interface between Cre recombinase monomers that 
could form a functional complex, yet be incompatible with the wild-type interface. The two sides 
of such an interface could then be mixed with the other sides of the wild-type interface to yield 
two distinct Cre mutants. These mutants, by virtue of possessing incompatible interfaces, could 
not form functional homotetrameric complexes, but could be combined to form a functional 
heterotetramer (Figure 2.1D). We selected the 2.2 Å crystal structure of a Cre-loxP Holliday 
junction (PDB code: 1KBU) (20) as our template for computational design. We then selected the 
largest monomer-monomer interface patch for redesign, focusing on residues that did not 
participate in any contacts with DNA (cyan oval on left side of Figure 2.2A). We used the 
Rosetta molecular modeling program to redesign five residues on each side of the interface (see 
Methods), although in some cases (two of ten) the wild-type amino acid was retained by the 
design calculation. The set of mutations that constitute the redesigned interface are the combined 
A1 and B1 mutations given in Table 2.1. When evaluated with the Rosetta full atom scoring 
function, the redesigned interface is 2.8 Rosetta units (RU) worse than the wild-type interface. 
Although the redesigned sequence was selected without regard for destabilizing mixed 
engineered/wild-type interfaces, models for the Cre-A1 and Cre-B1 homotetramer interfaces 
were predicted to be 9.8 and 20.49 RU worse than wild-type, respectively. Inspection of 
individual terms shows that the Cre-A1 and Cre-B1 models contain interface residues with side 
chains in strained conformations, presumably due to lack of favorable interactions. 
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We tested the redesigned interface by generating pairs of Cre mutants such that each 
mutant possesses one side of the interface, with the other side fixed as wild-type. We assayed 
members of each pair for recombinase activity in vitro both individually and in combination 
(Figure 2.3). While the combined pair of redesigned mutants was active (Cre-A1+Cre-B1 in 
Figure 2.3B; see Table 2.1 for mutations), one of the mutants (Cre-A1) was active individually, 
indicating that this hybrid redesign/wild-type interface was functionally compatible, in violation 
of our negative engineering goal (Figure 2.1D). 
Iterative rounds of rational design enhance the formation of (ABAB) complexes 
 We attempted to find another region of contact between monomers in the Cre complex 
that we could mutate in an attempt to further destabilize homotetrameric Cre-A1 complexes. 
Visual inspection of the Cre crystal structure revealed a salt bridge between Glu308 and Arg337 
(Figure 2.2C) that we hypothesized could be inverted to obtain additional specificity for the 
heterotetramic complex (Figure 2.2E). We therefore further mutated Cre-A1 (adding R337E) to 
yield Cre-A2, and mutated Cre-B1 (adding E308R) to yield Cre-B2. Thus, homotetrameric 
complexes of Cre-A2 would place two glutamate residues at 308 and 337 in close proximity, and 
Cre-B2 would likewise pair two arginine residues, yielding unfavorable electrostatic repulsion in 
either case. Our in vitro recombinase assay showed that the Cre-A2+Cre-B2 combination 
exhibited robust recombinase activity. However, while its activity is reduced relative to Cre-A1, 
the Cre-A2 monomer was still capable of forming a functional homotetrameric complex (Figure 
2.3B). 
 We selected a polar interaction between monomers as the final site for mutagenesis. We 
hypothesized that a replacement interaction consisting of hydrophobic residues would be 
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incompatible with the pre-existing polar interaction. Structural modeling suggested that the 
mutation E123L and Q35L could create a tight packing interaction between leucine residues 
across the monomer-monomer interface, but that interfaces combining a polar residue from the 
wild-type interface with either leucine from the engineered interface would be energetically 
unfavorable. 
In vitro assays indicated that the E123L mutation did indeed penalize formation of 
functional homotetrameric complexes, but that the Q35L mutation unexpectedly facilitated 
homotetramer formation in the previously inactive B2 mutant (data not shown). Consequently, 
we applied the E123L mutation to Cre-A2 to create Cre-A3. This mutation successfully disrupted 
formation of Cre-A2 homotetramers while preserving activity in the Cre-A3+Cre-B2 
heterotetramer (Figure 2.3B). The improvement in specificity appears to come from selective 
destabilization of the Cre-A3 homotetramer with limited destabilization of the heterotetramer.  
The reactivation of Cre-B1 by the Q35L mutation is especially puzzling, as the distance between 
the alpha carbon of position 35 and that of the nearest mutated position from Cre-B1 (position 76) 
is roughly 13 Å, suggesting that this mutation cannot directly alleviate the interface deficiencies 
introduced by the Cre-B1 mutations. This mutation may allow for a subtle rearrangement of the 
charged side chains at the interface that yields a functional complex through a mechanism that 
requires introduction of modes of relaxation that are not captured by our model. 
 To test whether our round 1 mutations are essential to enforce heterotetramer formation, 
we generated Cre mutants with only round 2 and round 3 mutations. The salt-bridge swap from 
round 2 alone yields two Cre mutants with reduced but clear activity (data not shown). We 
combined round 2 and round 3 mutations to create Cre-E123L-E308R and Cre-E123L-R337E. In 
vitro assays indicated that these mutants do not form an obligate heterotetrameric pair 
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(Supplemental Figure 2.1A). We conclude that the combined effects of mutations from all three 
rounds are necessary to achieve our design goal. 
Heterotetrameric mutations can be combined with DNA specificity altering mutations to 
enhance target site specificity 
 We hypothesized that the ability to control the assembly of functional Cre complexes 
would lead to higher fidelity recognition of asymmetric RT sites if used in combination with 
recombinases with different DNA specificities. Directed evolution has already been exploited to 
generate mutants of Cre recombinase that can utilize altered RT sites. A mutant (termed 
Cre-C2#4) with five amino acid mutations relative to wild-type has been shown to recombine an 
alternate RT site termed loxM7 (13). The monomer-monomer interface mutations from Cre-A3 
and Cre-B2 were applied separately to the Cre-C2#4 mutant. If the proteins with different DNA 
specificities exhibit the expected ABAB heterotetrameric pattern assembly, they should only 
recombine DNA half-sites with a specific spatial arrangement, yielding enhanced target 
specificity.  
To this end, we designed DNA substrates harboring direct repeats of six different 
loxP/M7 hybrid RT sites as a rigorous test of specificity (Figure 2.3C). We expect that a mixture 
of wild-type Cre and Cre-C2#4 (both of which lack our obligate heterotetrameric mutations) 
could recombine all of the six RT sites, as the individual monomers can combine in any manner 
dictated by the sequences of the RT half-sites. In contrast, a combination of the designed Cre-
A3-C2#4 and Cre-B2 recombinases, or similarly the Cre-A3 and Cre-B2-C2#4 recombinases, 
would specifically recombine the LM-LM site, but not the other five RT sites (Figure 2.3C). This 
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would imply that heterotetrameric Cre mutants will have less off-target activity when used for 
genome editing. 
 In vitro assays confirmed that the heterotetrameric Cre is more specific in recombining 
different arrangement of loxP/M7 sites (Figure 2.3D). Cre-C2#4 is slightly promiscuous, and can 
recombine loxP sites when incubated with DNA substrate for a long period of time ((13), 
Supplemental Figure 2.2B). The observed partial activity of the two designed pairs on LL-ML 
site (lane 2 in the middle and right gels of Figure 2.3D) is most likely the result of promiscuity of 
Cre-C2#4’s DNA specificity. It is also interesting to note that, because the four Cre monomers 
work cooperatively to recombine the DNA target, wild-type Cre and Cre-C2#4 homotetramers 
recombined most of the loxP/M7 hybrid sites on their own ((29), Supplemental Figure 2.1B). 
The specificity shown here by the two designed pairs provides strong evidence that our mutant 
recombinases indeed form an ABAB heterotetrameric complex. 
Obligate heterotetramer formation is preserved in mammalian cells 
 We envision RMCE in mammalian cells as the target application for our 
heterotetramer-forming Cre mutants. We employed two reporter systems to determine whether 
the engineered proteins satisfy our design goals in mammalian cells. First, we assayed the 
recombinase activity of the Cre mutants in a mouse ES cell reporter line by flow cytometry. We 
inserted a gene for the tandem dimer tomato (tdTomato) fluorescent protein downstream of a 
floxed stop codon at the rosa26 locus (Figure 2.4A). Constructs encoding genes for the Cre 
mutants driven by the haemoglobin beta (HBB) minimal gene promoter, either alone or in 
combination with one of two enhancers (see Methods), were transfected into the reporter line, 
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and the cells expressing tdTomato were quantified by flow cytometry (Figure 2.4B, 
Supplemental Table 2.1).  
Similar to the in vitro results, we observed the Cre-A2+Cre-B2 combination to be 
functional, while the Cre-A2 mutant retains significant activity as a homotetramer. Combining 
Cre-A3 with Cre-B2 yielded a suitable obligate heterotetrameric pair, retaining roughly 40% of 
wild type Cre activity. Neither the Cre-A3 nor the Cre-B2 mutants exhibited appreciable activity 
alone.  
We also evaluated the activity of the Cre mutants in mouse retinal explants. Dissected 
newborn mouse retinas were electroporated with a construct expressing GFP under the control of 
the rod photoreceptor-specific Nrl promoter (27) (as a loading control), Cre mutants under the 
control of the same Nrl promoter, and a floxed tdTomato reporter construct. After eight days in 
explant culture, the retinas were harvested, and imaged. The appearance of the flat-mounted 
retinas under epifluorescent illumination is shown in Figure 2.5. GFP fluorescence indicates 
areas of successful electroporation, and red fluorescence reports recombinase activity. Wild-type 
Cre shows robust activity, with all green cells also exhibiting red fluorescence (Figure 2.5A). 
The Cre-A3 and Cre-B2 mutants alone show very little activity (Figure 2.5B,C), while 
combining the two restores robust activity (Figure 2.5D). Quantification confirms that Cre-A3 
and Cre-B2 form an obligate heterotetrameric pair in photoreceptor cells (Figure 2.5E). 
DISCUSSION 
 We sought to engineer a pair of mutants of Cre recombinase that form an obligate ABAB 
heterotetrameric complex. The Cre-A3 and Cre-B2 mutants are the result of an iterative process 
of computational and rational protein engineering. We have shown that the two mutants are 
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inactive in isolation, but are functional when combined. Furthermore, we have shown that when 
additional mutations are used to confer an altered DNA specificity upon either one of the 
mutants, the arrangements of half-sites that are recombined are consistent with the formation of 
an ABAB complex. Although our attempts to confirm the composition of the functional complex 
directly via crystallography were unsuccessful, our data are strongly suggestive that we have 
succeeded in our goal. 
 Engineering a novel interface for Cre recombinase monomers that is incompatible with 
the wild-type interface involves two distinct requirements, one positive and one negative. The 
positive requirement is that the novel interface must give rise to a functional tetrameric complex. 
The negative requirement is that any combination of wild-type and engineered monomer surfaces 
must be functionally incompatible. We found that the negative engineering goal was more 
difficult to achieve. We were able to generate a novel functional interface using straightforward 
computational protein design. However, the mutations on one side of the interface (the Cre-A1 
mutations) were still compatible with the wild-type residues on the other side. We found that 
additional rounds of rational design were required to reduce the residual activity of 
homotetrameric complexes.  
A previous effort to create a heterotetrameric Cre complex identified concerted 
small-to-large and large-to-small hydrophobic mutations in an expression library that 
combinatorially mutagenized three tightly coupled residues (19).  The engineered interface was 
functional, but one of the mutant surfaces retained significant activity in complex with the 
complementary wild-type surface. Perhaps unsurprisingly, a small-to-large mutation was 
incompatible with the wild-type surface, presumably due to steric clash. However, large-to-small 
mutations exhibited reduced activity relative to wild-type, likely a consequence of creating a 
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cavity that destabilized, but did not destroy, the integrity of the interface. Although our mutations 
were selected to drive heterotetramer formation primarily based upon electrostatics rather that 
sterics, we ascribe our elimination of homotetramer activity to the increased number of residues 
and contact regions that we altered rather than the nature of the interactions that were altered or 
introduced. 
Researchers have successfully demonstrated a different strategy for partitioning Cre 
recombinase into two variants that are only active when combined. It has been shown that Cre 
recombinase can be split into N- and C-terminal fragments (split-Cre) that can reconstitute a 
functional complex when co-expressed in vivo by virtue of coiled coil dimerization tags 
appended to each fragment (30). The motivation for this approach was to place the split-Cre 
fragments under different promoters, yielding enhanced control over the cell types in which 
functional Cre complexes are present and resulting in highly specific conditional gene regulation. 
However, this approach to splitting Cre is not suitable for our purpose of combining monomers 
with different DNA specificities. Each split-Cre complex retains specificity for the loxP RT site. 
Even if specificities of the DNA-contacting regions are altered, the assembly of N and 
C-terminal fragments is uncontrolled, allowing for multiple combinations of half-site RT site 
specificities (16), and making this decomposition unsuitable for targeting asymmetric sites with 
high specificity. 
 CRISPR-based systems have emerged as an attractive tool for genome engineering due to 
the ease with which the Cas9 nuclease can be redirected to arbitrary targets (31-33). 
CRISPR/Cas technology represents the logical conclusion of modular DSB inducing agents, as 
the Cas9 nuclease can be targeted to any site that contains a protospacer adjacent motif (PAM) 
sequence (typically 3-5 bases in length) without mutating the protein itself. In cell culture, this 
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activity can drive the efficient generation of loss-of-function mutants when the DSB is repaired 
by non-homologous end-joining, or gene conversion when homology-directed repair occurs in 
the presence of an exogenously provided repair template (34). Given these features of 
CRISPR/Cas systems, what role can mutants of Cre recombinase play in genome engineering 
applications? 
Gene conversion by RMCE possesses advantages over DSB-induced gene conversion 
that are unique to enzymatically autonomous recombinases. A crucial advantage is that no other 
cofactors or endogenous cellular machinery are necessary. In particular, this avenue for genome 
editing does not rely upon the homology-directed DNA repair (HDR) system. The balance 
between DNA repair via HDR and via non-homologous end-joining (NHEJ) is highly dependent 
on cell type, and HDR itself is not a significant route for DNA repair in cells that are not 
replicating (3, 4). Thus, RMCE approaches may prove to be the only effective route to gene 
conversion for postmitotic cells, where DSB-induced HDR performs poorly. Furthermore, 
DSB-stimulated gene conversion is efficient over a relatively short range (~100 bp) (35). In 
contrast, cassette-mediated exchange is capable of correcting any mutation that falls within the 
RT site boundaries. Using RMCE, genetic intervals of >100kb of DNA have been exchanged, 
with the size of the interval limited by the size of the donor construct, and not by the method 
itself (36). 
 The disadvantage of targeting mutant recombinases to endogenous sites in a genome is 
the difficulty with which recombinase DNA specificity is altered. While directed evolution has 
proven to be successful in generating novel RT specificities, the compatibility of DNA 
specificity altering mutations with our interface mutations is a concern. Our results show that in 
at least one case (loxM7) the mutations that alter DNA specificity are compatible with our 
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mutations for controlling tetramer assembly. With respect to obtaining novel specificity Cre 
mutants, there is no realistic hope for any retargeting strategy that can rival the speed and ease of 
retargeting in CRISPR/Cas systems. We anticipate that endogenous site RMCE will be useful 
when a particular genomic locus is of sufficient interest to merit the effort required to obtain 
mutant recombinases whose RT specificities bracket the locus, or when there is a need to 
repeatedly exchange the DNA within the genetic interval. This may be the case when a locus 
harbors a large number of disease-associated polymorphisms that span several kb, or when a 
‘promoter bashing’ experimental approach is desired in an endogenous context.  
 We have presented an obligate heterotetrameric pair of Cre recombinase mutants. We 
have demonstrated that this pair can be used to form functional complexes that can recognize 
asymmetric RT sites. However, to realize the RMCE approach with maximal control over Cre 
complex formation, we will require a second pair of recombinase monomers to target the second 
asymmetric RT site that brackets the genetic cassette. This may be accomplished by engineering 
two additional Cre monomers that form a second obligate heterotetramer that is incompatible 
with the mutants we have described here. As this involves a large number of positive and 
negative constraints on monomer association, we suggest that an easier approach will be to use 
the knowledge of interacting residues we have identified in this study to direct rational redesign 
of the interface of a Cre homolog (37-39). Although no crystal structures are available for close 
homologs of Cre, sequence homology between recombinases has been recognized that could 
assist in generating obligate heterotetrameric mutants (37, 40). We are currently investigating the 
feasibility of this approach. 
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Cre mutant Mutations 
Cre-A1 K25R, D29R, R32E, D33L, Q35R 
Cre-B1 E69D, R72K, L76E 
Cre-A2 Cre-A1 + R337E 
Cre-B2 Cre-B1 + E308R 
Cre-A3 Cre-A2 + E123L 
Cre-B3 Cre-B2 + E123L 
 
Table 2.1. Mutations for each round of protein engineering. 
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Figure 2.1. Genomic applications of Cre recombinase. 
Depending on the number and relative orientation of the loxP sites, Cre recombinase can perform 
deletion, inversion, insertion or exchange of genetic content. (A) Direct repeats of the loxP site 
can be recombined to excise the intervening genetic interval (downward arrow). This reaction is 
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also catalyzed in the reverse direction, yielding a genetic insertion (upward arrow). For 
thermodynamic reasons, the excision reaction is favored, and insertion events occur with low 
frequency. (B) Inverted loxP repeats can be recombined to yield an inversion of the bracketed 
DNA. (C) Recombination at pairs of distinct RT sites gives rise to exchange of the intervening 
genetic ‘cassette’. (D) Cre recombinase is a homotetramer in its functional complex (wt Cre), 
imparting a preference for a symmetric RT as a consequence. As a first step to achieving 
recombination at asymmetric sites, we desire an orthogonal engineered interface between Cre 
monomers (eng Cre). We seek to construct a novel homotetramer Cre mutant with 
monomer-monomer interfaces that, while functional, are incompatible with the wild-type protein. 
Combining wild-type and engineered half-interfaces gives rise to two distinct mutants that 
cannot form functional complexes (mutants A and B). Combining the two mutants (denoted by 
‘M’) can reconstitute a functional heterotetrameric complex, which contains two wild-type and 
two engineered interfaces.  
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Figure 2.2. Mutated positions in the monomer-monomer interface. 
(A) The arrangement of Cre monomers on a loxP Holliday junction. The nucleic acid is shown as 
grey spheres, and each Cre monomer is rendered in a separate color. The largest area of contact 
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is indicated with a cyan oval on a side view of the complex (left side), and likewise the salt 
bridge that was inverted, shown in a bottom view (right side). (B) A set of interacting residues 
across the monomer-monomer interface was selected by eye for computational redesign 
(positions 25, 29, 32, 33, 35, 69, 72, 76, 119, and 123). The experimentally determined 
conformations of the sidechains at these positions are shown (PDB code: 1KBU ) (20)). In a 
third round and rational design, positions 35 and 123 were mutated to hydrophobic residues. (C) 
A putative salt bridge between a glutamate at position 308 and an arginine at position 337 is 
observed in the wild-type crystal structure. (D) The predicted model of the monomer-monomer 
interface after computational redesign is shown. The amino acids at positions 29 and 32 switch 
their electrostatic charge relative to wild-type, position 33 switches from charged to hydrophobic, 
and positions 76 and 35 switch from uncharged to charged amino acids. (E) A putative model for 
the charge swap at positions 308 and 337 preserves a salt bridge, but with a change in polarity.  
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Figure 2.3. In vitro recombination assay of Cre mutants. 
(A) In vitro recombinase assay. A 0.7 kb linear DNA substrate with direct repeats of the loxP site 
(orange triangles) is incubated with wild-type or mutant Cre recombinase. The activity of 
functional Cre complexes results in production of a 0.5 kb circular product and a 0.2 kb linear 
product through intra-molecular excision. (B) In vitro assay results. Lane 1: DNA substrate alone; 
lane 2: wild-type Cre; lanes 3-5: 1st round redesigned Cre mutants Cre-A1, Cre-B1 and a mixture 
of the two (CreA1+CreB1); lanes 6-8: 2nd round redesigned Cre mutants Cre-A2, Cre-B2 and a 
mixture of the two (Cre-A2+Cre-B2); lanes 9-10: 3rd round mutant Cre-A3 and a mixture of 
Cre-A3+Cre-B2. All Cre-B mutants are inactive in isolation. Cre-A mutants progressively lose 
homotetramer activity through the three rounds of design. (C) In vitro substrates for asymmetric 
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recombination target site experiments. RT half-sites in the linear DNA substrate described in 
panel (A) were systematically varied to incorporate the M7 sequence (13). LoxP and M7 
half-sites are rendered as green and red boxes, and abbreviated by the letters L and M, 
respectively. Combinations ranged from entirely loxP (LL-LL, the same as in panel (A)) to 
entirely M7 (MM-MM), including hybrid RT sites situated as both direct (LM-LM) and inverted 
(LM-ML) repeats. (D) The effect of controlled assembly of heterotetrameric Cre complexes. 
Each of the mixed loxP/M7 substrates was incubated with a pair of recombinases, one with 
mutations that recognize the M7 RT halfsite (Cre-C2#4) and the other with preference for the 
loxP half-site. In the left panel, the two proteins have no additional mutations to control complex 
formation. In the middle and right panels, recombinases with different RT specificities are 
combined with the Cre-A3 and Cre-B2 mutations, with both possible combinations tested. The 
restriction of permissible substrates by the Cre-A3 and Cre-B2 mutations are consistent with a 
requirement for an (ABAB) heterotetramer to achieve recombinase activity. 
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Figure 2.4. Cre mutant pair recapitulates requirement for heterotetramer formation in 
mouse ES cell cultures. 
(A) Diagram of the Cre-reporter cell line. The Cre-reporter cassette was inserted into the Rosa26 
locus, in the intron between endogenous exons 1 and 2. In the cassette, a red-fluorescent protein 
(RFP) is preceded by a floxed stop codon and followed by the woodchuck post-transcriptional 
regulatory element (WPRE). (B) Plasmids with the hbb minimal promoter driving expression of 
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different Cre variants either alone or augmented with the CMV or SP1 enhancers were co-
transfected into Ai14 mouse embryonic stem (ES) cells containing a fluorescent reporter cassette. 
The same total amount of DNA was used for all transfections, and 3 independent transfections 
were performed for each Cre variant. The percent of RFP positive cells was measured by flow 
cytometry. A total of 7000 cells were sorted after each transfection. The average number of RFP 
positive cells for each Cre variant or combination of variants is shown. For Cre-B2, Cre-A3, and 
Cre-A3, cell counts were less than five (out of 7000) for all promoter constructs (Supplemental 
Table 2.1).  
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Figure 2.5. Engineered Cre mutants retain preference for heterotetrameric complex in 
mouse retinal cells. 
Dissected newborn mouse retinas (with lens in place) were electroporated with constructs 
encoding: (1) Nrl-eGFP as a control for electroporation efficiency, (2) a reporter construct for 
Cre activity comprised of DsRed preceded by a floxed stop codon, and (3) a gene encoding 
either wild-type (panel A) or engineered Cre (Panels B-D) under control of the Nrl promoter. 
The left side of each panel shows the fluorescence from the green channel, which indicates cells 
that were successfully electroporated. Fluorescence from the red channel results from removal of 
the floxed stop codon, indicating Cre activity. The lens shows some autofluorescence which is 
apparent as a central circular region of red fluorescence in B, C, and D. (E) Quantification of 
activity of electroporated constructs relative to wild-type Cre.  
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Chapter 3 
Rec-Seq: A High-Throughput Specificity Assay for Recombinases 
 
This Chapter is adapted from a manuscript in preparation for publication. 
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ABSTRACT 
Cre recombinase is a member of the integrase family of site-specific DNA recombinases. 
The recognition site for Cre is the 34 base pair loxP sequence. However, the specificity of Cre is 
similar to a transcription factor in that it is tolerant of modest substitutions relative to the loxP 
sequence. We have developed a high-throughput assay (Rec-Seq) for characterizing the DNA 
specificity of recombinase activity. The assay employs a library of synthetic DNA substrates in 
which one of the four participating half sites has been fully or partially randomized. The library 
is incubated with purified recombinase and functionally tolerated members of the library are 
isolated by their altered size. We demonstrate the utility of the assay by characterizing the 
specificity of the wild-type Cre and VCre recombinases and their relative tolerance to base 
substitutions across their recognition sequences. We next apply the assay to evaluate the change 
in DNA specificity resulting from the directed evolution of Cre recombinase towards an altered 
DNA site. Finally, we utilize sequence analysis of recombinase homologs to predict the change 
in DNA site specificity due to an amino acid mutation, and use Rec-Seq to validate the predicted 
specificity determinant. 
INTRODUCTION 
Cre recombinase recognizes the 34 bp loxP recombination target (RT) sequence, and 
catalyzes a recombination reaction between two copies of loxP. The loxP sequence possesses 
pseudo-palindromic symmetry: inverted repeats of a 13 bp arm region are separated by an 
asymmetric 8 bp spacer region (1). Cre’s site specificity is predominantly exhibited in the 
recognition of the loxP arm regions. The enzyme is tolerant of many spacer region sequences, 
although recombination of two RT sites is dependent on the strong similarity, if not identity, 
between their spacer regions (2). 
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The Cre-loxP system requires no other cellular cofactors for robust activity, and has been 
employed for a number of genome engineering tasks. The most common is the creation of a 
conditional gene knock-out, in which a gene of interest is flanked by loxP sites, leading to loss of 
the gene in cells expressing Cre (3). The reversibility of this excision reaction can be exploited to 
achieve gene insertions, albeit at low efficiency (4). Pairs of loxP variants have been identified 
that could accomplish this insertion more efficiently (5). A more recent use of recombinases for 
genome manipulation is recombinase mediated cassette exchange (RMCE). In the RMCE 
approach, the genetic interval between heterologous RT sites can be exchanged from a donor 
DNA molecule to an acceptor. This has been demonstrated using several different 
recombinase-RT sequence pairs (6, 7). Recently, there has been increased interest in obtaining 
recombinase mutants with altered DNA specificity capable of recognizing sequences already 
present in human genomes (8-10).  
The discovery or engineering of recombinases with new RT specificities is of significant 
interest as a way to expand the utility of recombinase-based applications. Other than the 
Cre-loxP system, the most studied recombinase-RT pair is Flp-FRT, derived from the 2 µ 
plasmid of yeast. More recently, a number of Cre homologs have been reported, including the 
VCre-VloxP, SCre-SloxP, and Vika-vox systems. Many more homologs can be readily identified 
through searches of sequence databases, and in some cases their RT sequences can be predicted 
by analysis of the genomic context surrounding the recombinase gene body (11). Each newly 
identified RT sequence increases the likelihood that a given genetic locus harbors a subsequence 
similar to the DNA specificity of a known recombinase. 
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Directed evolution is a powerful tool for altering Cre’s DNA specificity. Buchholz and 
Stewart retargeted Cre to recombine a site from human chromosome 22 called loxH (9). The 
loxH site has four changes in the arm region and a different spacer region. They first randomized 
full length Cre recombinase by error-prone PCR. They used both positive and negative selection 
steps in vivo in bacterial cells. First, Cre mutants were evolved to recombine a loxP/loxH hybrid 
site for ten rounds. Then, Cre mutants were evolved for another ten rounds to efficiently 
recombine loxH full site. However, the resulting mutants were still able to recombine loxP sites 
with significant activity. Therefore, they performed fifteen additional rounds of negative 
selection to discourage Cre activity against loxP sites, while retaining the ability to recombine 
loxH sites. From the mutant library, a single clone called Fre22 was selected as the most specific 
mutant, with no activity for loxP and moderate activity for loxH. Another group used similar 
techniques to evolve the Flp recombinase towards a site in the human genome (8). Buchholz and 
colleagues also used directed evolution to evolve Cre to target a sequence in the long-terminal 
repeat of the HIV-1 strain (named loxLTR) (10). This asymmetric site has four changes in the left 
arm region and seven changes in the right, and has a different spacer region. The full length Cre 
sequence was randomized by error-prone PCR. They used an iterative positive selection strategy, 
sequentially targeting intermediate half-sites, separate symmetric half-sites, and finally the full 
asymmetric site. Surprisingly, although the two half-sites have different sequences, they were 
able to obtain a Cre mutant that could recombine the asymmetric RT site after 126 rounds of 
directed evolution. The final Cre mutant (called Tre) successfully recombined the loxLTR sites 
in vivo, resulting in excision of the proviral HIV genome in cultured cells (10). 
Using a different strategy, Santoro and Schultz retargeted Cre to recombine loxM7 sites, 
which contain three substitutions to each arm region of the loxP site (12). They used a focused 
62 
 
mutational approach in which only five residues in the Cre protein (identified from the crystal 
structure) were randomized. They used GFP and RFP as reporter genes, and FACS sorting to 
separate functional clones.. They also directly compared directed evolution using only positive 
selection with an approach that incorporated negative selections in the later rounds. They 
performed three rounds of positive selection on two libraries and five alternating rounds 
positive/negative selection on another two libraries. Mutants obtained from just positive selection 
were generally promiscuous in recombining both loxP and loxM7 sites, while mutant coming 
from alternating rounds of positive and negative selection exhibited much better specificity. A 
clone (named CreC2#4) was chosen as the most specific recombinase for the loxM7 site.  
A current weakness of directed evolution applied to selection of novel recombinase 
specificities is that there is no assay for assessing the specificity of the resultant mutants across a 
full RT half-site. The selections or screens used to identify recombinases with activity towards a 
desired novel RT site only report on the activity of the recombinase against a single site. Often, a 
negative selection is applied by screening the mutant library for activity against the relevant 
wild-type RT site for the recombinase used as the starting point for evolution. In one directed 
evolution effort, it was subsequently discovered that although a mutant with activity against the 
desired novel RT site had indeed been obtained, the mutant actually had a stronger preference for 
an entirely different RT site (8). This underscores the necessity to take into account not just the 
desired activity, but also activity against all other possible substrates when assessing the 
specificity of recombinases. This is a daunting task in the context of mammalian cells. 
A sequencing study had been published for loxP spacer region specificity and 
compatibility (13), but the specificity in the arm region have not been thoroughly characterized. 
A previous randomized library approach to identifying alternative lox sites showed some Cre’s 
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sequence preferences in vivo (14), but did not yield highly specific data because Cre recombinase 
was highly promiscuous in their experimental settings. In this manuscript, we overcame the 
promiscuity issue by adjusting salt concentrations in vitro, and used high-throughput sequencing 
to determine Cre’s DNA specificity. 
In this manuscript we describe a high-throughput assay for the specificity of DNA 
recombinases that we have named Rec-Seq. Using this assay we have characterized the 
specificity of the arm region of Cre recombinase. We also present the experimentally determined 
specificity for the VCre recombinase, a homolog of Cre with a different recombination target site 
sequence. We furthermore assess the specificity of a Cre mutant that has been obtained by 
directed evolution to exhibit altered DNA specificity in a subset of the arm region (12), giving a 
clearer evaluation of the nature of the specificity change. Finally, we demonstrate how the simple 
consideration of amino acid-base correspondences between members of the tyrosine recombinase 
family can uncover specificity determinants in protein alignments. We validate the utility of this 
method for identifying specificity-altering mutations by characterizing the changes in specificity 
that result from the identified amino acid mutation. 
MATERIALS AND METHODS 
Molecular cloning, expression, and purification of recombinases 
Genes encoding N-terminal His7-tagged recombinase were cloned into a pET42a vector 
using standard molecular biology techniques. Proteins were expressed in ArcticExpress cells 
(Agilent Genomics) at 20°C for 48 hours using the autoinduction protocol of Studier (15). 
Recombinases were purified using a HisTrapTM HP column (Amersham) following protocols 
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described previously (16). Protein concentrations were determined by UV absorbance using an 
extinction coefficient at 280nm of 49 mM-1cm-1 for Cre and 51 mM-1cm-1 for VCre. After 
purification, the proteins were stored at 4° C. 
Library preparation for Illumina sequencing 
Primers and library sequences are described in supplemental materials and Supplemental 
Table 3.1. The substrate libraries were generated by PCR amplification of pBAD33 vector’s 
multiple cloning site, with the Library-forward and Library-reverse primers. 700ng of the 
substrate libraries were incubated with 3 µM recombinase protein in 10 µL of 50 mM Tris-HCl, 
pH 7.8, and 10 mM MgCl2 for 20 hours at 37° C. NaCl conditions for each assay are described in 
Supplemental Table 3.1. The reactions were stopped at 98° C for 10 minutes, and then diluted to 
50 µL. The mixtures were digested the XbaI restriction enzyme (NEB) to prevent PCR 
amplification of the 824 bp substrate in the next step, ensuring that only the 97 bp recombination 
product can be amplified (Figure 3.1). The selection sequencing libraries were generated by PCR 
with primers pair Selected-sequencing-forward and Sequencing-reverse, using 5 µL of the above 
digested mixture as template. The background sequencing libraries were generated with primers 
pair Unselected-sequencing-forward and Sequencing- reverse, using 1 µL substrate libraries as 
template. Both libraries were amplified by Q5® DNA polymerase (New England Biolabs) using 
two-step protocol, 30 cycles, 15 s extension time. 
High-throughput sequencing data analysis 
For each individual sequence, the enrichment over background is calculated as:  
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𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸𝐸ℎ𝑚𝑚𝑚𝑚𝐸𝐸𝑚𝑚(𝑠𝑠𝑚𝑚𝑠𝑠) = 𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
𝑁𝑁𝑏𝑏𝑏𝑏
𝑠𝑠𝑠𝑠𝑠𝑠
𝑁𝑁𝑏𝑏𝑏𝑏
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑠𝑠
𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠
𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑠𝑠  
where 𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠
𝑠𝑠𝑠𝑠𝑠𝑠 and 𝑁𝑁𝑏𝑏𝑏𝑏
𝑠𝑠𝑠𝑠𝑠𝑠 are the number of occurrences of the individual sequence in the 
selected and background libraries, respectively, and 𝑁𝑁𝑠𝑠𝑠𝑠𝑠𝑠𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑠𝑠  and 𝑁𝑁𝑏𝑏𝑏𝑏𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑠𝑠  are the total number of 
sequence counts in the selected and background libraries. For the 4N, 5N and 6N libraries, 
sequences with enrichment of less than 2.5 were discarded. For the 9N libraries, sequences with 
enrichment of less than 8 were discarded. Sequence logos were generated by Weblogo3 (17) 
using enrichment data as input. 
Identification of Cre homologs and prediction of their RT sites  
We identified homologs of Cre recombinase by performing a PSI-BLAST search of the 
wild-type Cre sequence against the NCBI set of non-redundant protein sequences, using the 
default settings (18). For homologs that were close but not identical in sequence identity (30-45% 
identical), we downloaded the complete genome or shotgun sequencing contig containing the 
coding region for the protein. We wrote a simple computer program to analyze the sequencing 
files and identify 34 bp sequences with pseudo-palindromic symmetry. The outer 13 bp flanks 
were compared for inverted repeats. The 8 bp spacer regions were ignored. A user-specified 
number of mismatches between the putative arm regions were allowed. We had two 
requirements for a sequence to qualify as an RT prediction. First, we allowed at most one 
deviation from inverted symmetry in the arm regions. Second, the putative RT sequence had to 
be located within 2 kbp of the coding region for the homologous gene. 
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RESULTS 
A high-throughput assay of recombinase DNA specificity 
Assessing the DNA specificity of a recombinase involves identifying not just the 
preferred RT sequence, but also the relative impact of base substitutions throughout the RT site. 
The DNA binding specificities of transcription factors (TFs) have been determined via 
high-throughput sequencing of the bound subset of randomized DNA binding sites (19). In 
contrast, tyrosine recombinases exhibit their specificity in an enzymatic reaction in which two 
RT sites are cleaved and religated. We have established an in vitro assay to determine the DNA 
specificity of Cre recombinase using the successful completion of the DNA splicing reaction as a 
selection method (Figure 3.1). We generate a library of linear DNA substrates (824 bp) for 
recombination by PCR. The RT sites are incorporated into the PCR primers, allowing for ready 
substitution of the half-site sequences and different choices of randomized bases. The library is 
incubated with purified recombinase to initiate the reaction. Successful recombination results in 
a small 97 bp linear product containing the functionally competent members of the randomized 
library, and a 727 bp circular product. The reaction mixture is then digested by XbaI to prevent 
PCR amplification of unreacted substrate in the following step. The 97 bp product is 
subsequently amplified by PCR to generate the selected sample, and a background sample for 
comparison is generated by PCR amplification of the unreacted 824 bp substrate. Both the 
background and selected library samples are subjected to high-throughtput sequencing. 
We have tested various library designs and conditions for Cre variants and homologs 
(Supplemental Table 3.1). We observed no recombination when Cre was incubated with a library 
in which the entire 13 bp half-site was randomized (13N library), and low sequence specificity 
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with a library in which the outermost nine bases were randomized (9N library)(Supplemental 
Figure 3.1A). The low activity was likely the result of the high complexity of the 13N library, 
and the low sequence specificity was likely the result of non-specific recombination driven by 
the cooperativity of the Cre complex. As has been shown previously, Cre monomers assemble 
cooperatively to form a functional tetrameric complex (14) (16). When the three non-randomized 
RT half-sites are the preferred loxP sequence, we observed promiscuous recombination of the 9N 
library. We then tried to reduce the cooperativity by mutating the half-site next to the 9N library 
to the loxM7 sequence (12)}, hypothesizing that the reduced affinity of Cre for this half-site 
would reduce the overall cooperativity for the reaction. In line with this expectation, we observed 
increased specificity from the 9N library that is consistent with the expected loxP sequence 
(Figure 3.2).  
For experiments with recombinases other than Cre, we do not have known weak RT sites 
analogous to loxM7. Furthermore, we would like to use native RT sites when possible. We found 
that we could obtain higher specificity profiles when randomized libraries with lower complexity 
were used, even without changing the loxP sequence at the non-randomized half-sites. Therefore, 
for subsequent specificity assays, we broke the 13 bp arm region into overlapping windows of 5-
6 bp, performing independent experiments randomizing one window at a time. 
NaCl concentration has a large effect on observed in vitro specificity 
One obstacle that prevented us from observing highly specific recombination is the 
cooperativity of DNA binding in Cre tetramers. At pH 7.8, Cre forms tetramers and are more 
active but less soluble at low salt conditions (<300 mM NaCl) but remains mostly monomeric 
formations at 700mM NaCl (20). Most previous in vitro recombinations were reported in low 
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salt conditions (~50 mM NaCl) (12) (13, 21). We proposed that at higher NaCl concentration, 
Cre’s interaction between monomers would be compromised, so that Cre would become less 
cooperative, and the reactivity of the library members would be less dependent on the sequences 
of the non-randomized half-sites. 
We sequenced the recombination product from the randomized substrate library shown in 
Figure 3.2 after incubation in 4 different salt conditions: 120 mM, 170 mM, 200 mM and 210 
mM (Figure 3.2, Supplemental Table 3.1). As expected, Cre’s specificity increased with the salt 
concentration. However, there was no detectable recombination product for this library when we 
raised the NaCl concentration above 210 mM (Supplemental Table 3.1). In order to obtain highly 
specific recombination, we tried to raise the salt concentrations as high as possible while still 
permitting detectable activity in all following assays. Unfortunately, the optimal salt conditions 
to use are dependent on both the recombinase and the substrate sequences. Therefore we 
empirically identified the concentration to use for each assay (Supplemental Table 3.1). 
Sequence specificity for Cre variants and homologs 
We applied the window approach to assess the DNA specificity of wild-type Cre 
recombinase throughout the full loxP arm region (Figure 3.3). The location of the randomized 
windows relative to the arm region sequence are indicated, and sequence logos for each of these 
experiments are shown. We also tested the sequence preference of Cre within a window that 
included the first base pair of the spacer region (Supplemental Figure 3.1D). Cre makes a single-
stranded break after the 1st base on the top strand and before the 8th base on the bottom strand in 
the spacer region. Homology is required for the intervening 6 bp sequence for strand exchange. 
We attempted to test the specificity of the spacer by randomizing half of the bases in this region, 
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but did not observe any recombinant product (Supplemental Table 3.1). In all the reported 
windows in the arm region, the consensus loxP sequence was the most enriched sequence. For 
the first base pair of the spacer region, Cre showed a strong preference against cytosine 
(Supplemental Figure 3.1D). Although the overlapping bases between different windows show 
preferences for the same bases, the relative information contents can be quite different. We 
attribute the discrepancies to the differences in the substrate and salt conditions between assays. 
The discrepancies prevent us from combining the overlapping windows to show a single logo for 
the full half-site. Therefore, we report the results for each window independently in this 
manuscript. 
In recent years, Cre homologs targeting different RT sites have been found. Such 
additional homologs are particularly useful in RMCE applications, where two recombinases can 
be used simultaneously for genome cassette exchanges (22). We set out to determine detailed 
sequence specificities for the VCre recombinase (23). VCre recombines VloxP sites (Table 3.1) 
and the purified protein was active in our in vitro assays (Figure 3.4, Supplemental Figure 3.1C). 
In the absence of other detailed studies, we assumed that the 34 bp VloxP site possesses the same 
structure as loxP, containing two 13 bp arm regions and an 8 bp spacer region. Interestingly, the 
two arm regions of VloxP site are not strictly inverted repeats containing a mismatch at position 
9. Results detailing the sequence specificity of VCre using three randomized windows over the 
arm region are shown in Firgue 4. By comparing the logos between Cre and VCre, we found that 
the two recombinases showed strong sequence preferences at different positions. Cre showed 
strong preference at position 2, 7, 8, 11, 12 and 13, while VCre showed strong preference at 
position 1, 3, 6, 7, 12, 13, suggesting the possibility of slightly different DNA binding modes. 
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VCre showed the least sequence preference at position 9, consistent with this being the position 
of the mismatch between the arm regions in VloxP. 
Probing the sequence specificity of an evolved recombinase 
The ability of directed evolution to generate recombinases that can operate on novel RT 
sites has been demonstrated repeatedly. However, the process can be time consuming and 
laborious, especially if the desired RT site is significantly different from any known wild-type 
RT sequence. To accelerate the process of retargeting recombinases, we propose to use sequence 
analysis of homologs of Cre. PSI-BLAST searches of bacterial genomes using Cre recombinase 
as a starting template identify hundreds of Cre homologs. Using custom software to scan the 
surrounding genomic context for the open reading frames of these homologs, we are able in 
many cases to predict their RT sequences. Closely related homologs share similarity in both 
amino acid sequence and predicted RT DNA sequence. Using the crystal structure of Cre bound 
to loxP (PDB code: 1KBU (24)), we are able to infer determinants of specificity by inspecting 
coordinated amino acid and base changes that map to interacting regions of the structure. As a 
demonstration, we picked a group of Cre homologs with predicted RT sites that switched from 
loxP to loxTA at position 8 and 9 (Figure 3.6). In the Cre-loxP structure, these bases are 
contacted by an alpha helix. Inspection of a multiple sequence alignment of the residues in this 
helix suggested the R259P mutation as a good candidate (Figure 3.6C). 
We expressed and purified the Cre R259P mutant to assess the validity of the putative 
R259P specificity determinant. First, we performed in vitro activity assays with Cre and Cre259P 
on the loxP and loxTA sequences (Figure 3.7A,B). The assays showed that Cre and Cre259P can 
recombine both loxP and loxTA, and there was no observable difference in specificity between 
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Cre and Cre259P. This indicates that the R259P mutation does not have enough of an effect on 
specificity to prevent recombination at loxP sites. We used Rec-Seq to look for more subtle 
changes in specificity. We designed a 4 bp randomized library centered on the base substitutions 
in loxTA relative to loxP and used high-throughtput sequencing to examine Cre259P’s DNA 
specificity in greater detail (Figure 3.7C-E). The resulting logo shows there is indeed a 
specificity switch caused by Cre259P. We tried additional mutations suggested by the sequence 
alignment at positions 258, 263 and 266, but did not observe increased specificity for any (data 
not shown). Although Cre259P does not result in a strict change in specificity, the ready 
availability of this mutation makes the search for loxP-like sequences more tolerant at these 
positions, and the Cre259P mutant can be used as an alternate starting point for directed 
evolution if the desired RT site matches loxTA better than loxP. We expect that the wealth of 
sequence data for recombinase homologs can be ‘mined’ to identify many more specificity 
determinants that can be helpful in this regard as well. 
DISCUSSION 
Cre recombinase and related homologous recombinases are attractive tools for genome 
engineering. Here, we have presented a high-throughput method to study the DNA specificity of 
recombinases. In some instances the native RT sequences of Cre homologs are not difficult to 
identify. The RT sites are assumed to adopt a loxP-like structure, usually located close to the 
genes that encode the recombinases in the genome (11). However, characterizing the DNA 
specificity of recombinases involves more than just knowing the native RT sequences. These 
recombinases may recombine other RT sites with relatively high efficiency, generating off-target 
activity. Furthermore, if we want to engineer the recombinases to retarget other RT sites, it will 
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be advantageous to know at which RT positions the recombinases are tolerant of substitutions, 
and are subsequently easier to retarget. 
 
The Rec-Seq method we have established reports on in vitro recombination of 
randomized DNA substrate libraries. A previous randomized library approach showed Cre can 
be quite promiscuous in vivo (14). In their in vivo study, when three out of four arm region were 
kept constant loxP sequence, Cre can recombine randomized arm regions even when 12 out of 13 
bases are different from loxP. The promiscuity with respect to the randomized region is not 
entirely surprising, given the strong cooperativity of Cre. However, this feature of Cre makes it a 
difficult task to accurately assess its DNA specificity. We have addressed this issue in vitro in 
two ways. First, we have intentionally introduced suboptimal sequences(loxM7 for Cre) in the 
constant arm regions to reduce binding in the unrandomized half-sites. However, for proteins 
other than Cre, we will not have sufficient knowledge to design suboptimal, yet still functional, 
sites. We have explored a second, more general approach in which the salt concentration is tuned 
to weaken the protein-DNA interactions. This leads to a stronger requirement for recognition 
between the recombinase and the randomized region of the substrate, yielding results that exhibit 
stronger specificity. Drawbacks of in vitro recombination in the Rec-Seq method include the 
effort required to obtain purified protein, and the inability to study interesting recombinase 
variants with known in vivo activity, but with insufficient activity in vitro to extract meaningful 
results. We are exploring the possibility of creating an in vivo version of Rec-Seq that overcomes 
the previously observed problem of high cooperativity. 
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We have adopted a window/tiling approach to characterizing the specificity of 
recombinases. Assaying the entire arm regions requires high complexity libraries that contain 
mostly inactive members, and in our case, did not generate detectable recombination product 
(Supplemental Table 3.1). The windowed approach is particularly suitable for situations where 
evaluating the specificity of a recombinase for a subset of the arm region is the goal. This is the 
case for our sequence-based approach to identifying specificity-altering mutations targeting a 
pair of bases. It is also appropriate for validating recombinase variants coming from directed 
evolution to target novel RT specificities. When the desired RT has quite a few mismatches to 
the native RT sequences, specificity alteration is often achieved in a series of intermediate steps, 
each of which focuses on the specificity switch on only a few base pairs, making it suitable for 
validation using a window approach (9, 10). The caveat of the windowed approach is that the 
recombination of each randomized window may be context dependent, and the windows may not 
be able to be stitched together for presentation of the specificity of a full arm region.  
 
Retargeting recombinases to novel RT sites is a laborious process involving many rounds 
of directed evolution. In a recent effort, Buchholz and colleagues applied a total of 126 rounds of 
directed evolution to evolve Cre to target long-terminal repeat of HIV-1 strain (10). Although, 
the ease of retargeting recombinases will never approach that of CRISPR/Cas systems, the 
unique capabilities of this family of proteins justify efforts to accelerate the retargeting process. 
The Rec-Seq method can be very useful in this regard. First, we can use Rec-Seq to identify the 
bases in the RT sequence for a recombinase that are less difficult to change. Second, with the 
help of sequence alignment of Cre homologs, we can identify possible candidate mutations for 
altering specificities. We can then validate these candidate mutations individually using Rec-Seq 
74 
 
to build a database of mutations and their corresponding changes of RT site specificities. By 
gathering the positions on the RT sequence that are relatively easy to alter and the database of 
specificity altering mutations, we can screen for DNA elements in a genomic interval to find 
those targets for which retargeting is most likely to be successful. By prudent selection of RT 
targets and incorporation of a small number of previously characterized mutations, the burden 
placed upon and hopefully the experimental effort required for the directed evolution process can 
be reduced. . Third, Rec-Seq can serve as a criterion for when the cycles of directed evolution 
selections can be terminated. Finally, in past efforts, recombinases have been evolved for one 
sequence, but exhibited even stronger activity for another (8). Rec-Seq could identify this 
problem before efforts are expended in cell culture experiments. 
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LoxP ATAACTTCGTATA GCATACAT TATACGAAGTTAT 
LoxM7 ATAACTCTATATA GCATACAT TATATAGAGTTAT 
LoxTA ATAACTTTATATA GCATACAT TATATAAAGTTAT 
VloxP TCAATTTCCGAGA ATGACAGT TCTCAGAAATTGA 
 
Table 3.1 34 bp full recombinase target sites 
  
79 
 
 
Figure 3.1 Randomized library construction and in vitro assay for recombinase specificity. 
An 824 bp DNA substrate containing a direct repeat of two target sites is generated by 
PCR. The asymmetric spacer region is represented as an orange triangle. Three out of the four 
half-sites are kept constant (green), while one arm region contains randomized libraries (blue). 
The library is incubated with purified recombinase at 37℃ overnight. After recombination, the 
substrate is resolved into a 97 bp small linear product containing the primer sites and a 727 bp 
circular product. Recombined members of the library are amplified by PCR with primers 2 & 3 
(black arrows) for subsequent sequencing. For comparison, a background library is generated by 
PCR using primers 1 & 2, and the starting 824 bp substrate as template. 
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Figure 3.2 Recombinase specificity as a function of salt concentration 
Wild-type Cre protein was incubated with a substrate library comprised of a loxP RT site 
(green boxes) and an RT site with a loxM7 half-site (yellow box) and a loxP half-site with the 
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outer nine bases randomized (blue box). The reaction was performed in different NaCl 
concentrations. The sequence was read from a reverse primer, indicated by the arrow above. The 
results are reported with the outermost position (1) shown on the left, and the innermost (9) 
shown on the right. The corresponding region of the loxP arm region is shown with the 
randomized portion underlined. Results are shown for experiments including NaCl 
concentrations of: (A) 120mM, (B) 170mM, (C) 200mM and (D) 210mM. 
  
82 
 
 
Figure 3.3 Sequence preferences of wild-type Cre recombinase in the arm region 
The results of three tiled Rec-Seq experiments that cover the loxP arm region are 
presented. Sequence logos depicting the enrichments at each position are aligned with the 
corresponding randomized windows of the loxP arm region (denoted by black bars). At each 
position, the most enriched base agrees with the loxP sequence, although the relative tolerance 
for alternate bases varies greatly across the arm region. 
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Figure 3.4 Sequence preference of Vcre recombinase in the arm region 
The results of three tiled Rec-Seq experiments assaying the specificity of the VCre 
recombinase over the arm region of VloxP are shown. The substrate library (top) includes the 
VloxP sequence for the spacer, 3 unrandomized arm regions, and a randomized arm region, with 
the location of the sequencing primer annealing region denoted with a black arrow. Sequence 
logos depicting the enrichments at each position are aligned with the corresponding randomized 
windows of the VloxP arm region (denoted by black bars). The Rec-Seq results for VCre at each 
position confirm that the most enriched base agrees with the VloxP sequence. Position 9 of VloxP 
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is a mismatch between the two arm regions of VloxP, with T and C bases present in the left and 
right arm regions. We find this position to have very little specificity (note the low information 
content for position 9 in the 5-10 position library). 
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Figure 3.5 Sequence preferences of CreC2#4 recombinase in the arm region 
Rec-Seq experiment results are presented as sequence logos for the CreC2#4 altered 
specificity mutant. The substrate library consisted of three loxM7 arm regions and one arm 
region that randomized bases in a loxM7 background in three windows. This mutant was 
selected to recombine the sequence of CTA at positions 7-9 of the arm region. The results show 
that specificity was indeed switched at positions 8 and 9, but that specificity is lost at position 7. 
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Figure 3.6 Identification of a specificity determinant via sequence comparison of 
recombinase homologs. 
(A) An alignment of the known and predicted arm region sequences for Cre recombinase 
and close homologs are shown, with the source organisms noted. Each homolog recognizes an 
RT with the sequence TA at positions 8 and 9 (shown in green). The loxTA arm region is an 
altered loxP sequence with only these two base substitutions. (B) The model for the Cre-loxP 
complex (PDB code: 1KBU (24)) is shown, with positions 8 and 9 of the arm region rendered in 
green. Residues 256-279 of the protein (rendered in magenta) are in close proximity to these 
bases. (C) An alignment of the amino acids for each of the Cre homologs in the range of residues 
256-279 (Cre numbering) is shown. The consistent difference between the homologs and Cre 
itself is an arginine to proline substitution at position 259.  We use Cre259P to denote a Cre 
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variant with this single mutation. (D) A structural model of the region of interaction between 
CreR259P and loxTA was predicted using the Rosetta design program. The substituted proline 
residue (rendered as spheres and colored magenta) is predicted to make hydrophobic interactions 
with the methyl groups of the thymine bases at positions 7 and 8, and on the opposite strand from 
position 9 (shown in yellow). 
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Figure 3.7 Validation of R259P specificity determinant by Rec-seq 
(A) In vitro assay for recombinase activity. The substrate for the assay is a linear DNA 
molecule harboring direct repeats of either the loxP or loxTA RT. Recombination results in 
generation of smaller circular and linear products. (B) Both wild-type and Cre259P recombinases 
were incubated with substrates containing both loxP and loxTA repeats in the presence of 
120mM NaCl. We observe activity for each combination, indicating that DNA sequence 
preferences are too subtle to observe with a bulk assay such as this. (C) The results from a Rec-
Seq experiment are shown in logo form for the window covering positions 7-10 of loxP (these 
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columns were extracted from the 6 bp window experiments shown in Fig. 3). (D) An alignment 
of loxP with loxTA is shown, with the differing bases colored red, and with black bars indicating 
the positions shown in the sequence logos. (E) A sequence logo for the results of a Rec-Seq 
experiment randomizing the four bases at positions 7-10 for loxTA is shown. The most enriched 
sequence corresponds to loxTA, indicating that the R259P mutation results in the desired switch 
in specificity. 
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Chapter 4  
Conclusions and Future Directions 
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Design of recombinases for asymmetric sites 
The tetrameric protein complex of Cre recombinase imposes a symmetric constraint on 
the RT sites it recombines. As a result, the utility of recombinase mutants with altered DNA 
specificity is limited if the pool of potential genomic targets must satisfy this constraint. A pair 
of ‘orthogonal’ recombinases with independently altered DNA specificities can overcome this 
challenge, allowing for the recombination of asymmetric sites. In chapter 2, I used both 
computational and rational design to construct a pair of obligate heterotetrameric Cre monomers: 
these mutants are active when combined together, but inactive in isolation. I found it relatively 
easy to reconstruct the protein-protein interface to find a pair of monomers that could work 
together. However, it is much harder to completely “knockout” the activity of the monomers in 
isolation. In chapter 2, I found that three successive rounds of design were necessary to achieve a 
completely orthogonal pair of Cre recombinases. 
Prospects for additional heterotetrameric recombinase pairs 
Recombinase-mediated cassette exchange (RMCE) at native loci is a promising strategy 
to precisely replace defined intervals in the genome with any sequence provided in a DNA 
template. During the cassette exchange, there are two distinct recombination crossover events, 
requiring two sets of orthogonal recombinases. For maximal specificity, we require a second pair 
of obligate heterotetramer recombinase mutants. One possible way to finding such a second pair 
of recombinases is to redesign another novel interface for Cre monomers and demand that it to 
be incompatible with both the wild-type interface and the redesigned Cre-A3/Cre-B2 interface. 
Considering that I found the negative elements of interface design to be more difficult to satisfy 
than the positive elements, this approach seems difficult to achieve. Another strategy is to 
engineer homolgous DNA recombinases that will not cross-react with Cre. A group of 
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researchers have used both Cre and Flp to demonstrate RMCE (1). They found that Flp is not as 
efficient as Cre in vivo, and that a careful balance of the proteins are needed to optimize cassette 
exchange efficiency. 
Several new Cre homologs have been found by screening bacterial genomes.  Examples 
include Vika, SCre and VCre (2, 3). They share around 30% sequence identity to Cre and 
recombine distinct RT sites. It is likely that they will not cross react with each other, making 
them ideal candidates to engineer for RMCE. The caveat is that these recombinases are less well 
studied. In particular, there are no crystal structures available for these homologs. Therefore, 
interface design for these proteins relies on guessing the contacting residues by mapping their 
protein sequence onto Cre’s crystal structure. Using this strategy, I have tried to engineer the 
protein interfaces of Vika and VCre recombinase. For Vika recombinase, I used rational design 
and introduced “charged swaps” into the interface. I found a pair of mutations (R33D and E72R) 
and an in vivo assay showed that they were active when combined together.  However, one of the 
mutants has reduced but clear activity in isolation. Additional mutations are needed to engineer a 
completely orthogonal pair. For VCre, more aggressive measures were taken.  I have tried 
exchanging pairs of interacting alpha-helical elements of secondary structure between VCre and 
a close homolog. The resultant VCre variants were non-functional and additional mutations to 
other residues that intact with the helix are required to rescue the activity. 
A future approach to overcome the limited success of sequence-based methods may 
involve crystallographic efforts to obtain experimentally determined structures for VCre, Vika, 
or other recombinases. This would allow for the application of the structure-based strategies that 
I used successfully with Cre recombinase. The availability of many recombinase homologs, with 
associated predictions for RT sites, will allow us to select recombinases that target diverse RT 
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sequences for structural characterization, which would simultaneously expand the genomic 
sequences we can target for cassette exchange. 
Rec-Seq is a powerful tool to study the DNA specificity of recombinases 
Using recombinases in genome editing not only requires the knowledge of their native 
RT sites, but also requires a quantitative understanding of base preferences at all of the positions 
in the RT site. In chapter 3, I described a method call ‘Rec-Seq’ to fully characterize the DNA 
specificity in the arm region using high-throughput sequencing.  This assay is also crucial for 
testing and validating recombinase variants obtained from directed evolution.  
A possible future direction for Rec-Seq would be to adapt the method for in vivo 
recombination.  As described in Chapter 3, the recombination step was performed in vitro. 
Compared to in vivo methods, in vitro recombination has several advantages. First, the 
randomized library size is not limited by bacterial transformation. As long as there is detectable 
product, there is no limit on how many positions can be randomized at the same time. Second, 
Cre’s strong cooperative binding of the RT site (which has hindered previous specificity assays) 
can be reduced by adjusting the NaCl concentration. It is difficult to change the conditions 
similarly in vivo. On the other hand, recombination in vitro requires a time consuming protein 
purification step, and some recombinases do not express well or are not sufficiently active in 
vitro. As a result, I could not use Rec-Seq to test several recombinases of significant interest. For 
example, the wild-type Vika recombinase does not express well, and the engineered Fre22 and 
Tre recombinases have prohibitively weak activity in our in vitro assay, although they exhibit 
activity in bacterial or mammalian cells. Thus, it would be advantageous to develop a Rec-Seq 
method in vivo. The in vitro DNA substrate used in chapter 3 can be cloned into a pBAD33 
94 
 
vector where the corresponding recombinases express under the control of arabinose induction. 
After transformation and arabinose induction in E. coli, I can perform a miniprep, use similar 
procedures to PCR amplify the recombined product and send the amplified DNA to Illumina 
sequencing. By controlling the recombinase expression with arabinose levels, this proposed in 
vivo method can be used to detect recombinases that have little activity in vitro. One drawback of 
this in vivo method is that the recombinases, especially wild-type Cre, may be too promiscuous 
to yield highly specific recombination product. It is necessary to tune the arabinose level and 
modify the substrate sequence to obtain optimal recombination specificity. 
Accelerating the retargeting of recombinases  
Compared to the ease with which the CRISPR/Cas system can be retargeted, altering the 
RT site specificity of recombinases is a laborious process, involving many rounds of directed 
evolution. In a recent effort, Buchholz and colleagues applied a total of 126 rounds of directed 
evolution to evolve Cre to target long-terminal repeat of HIV-1 strain (4). The number of rounds 
of directed evolution could be reduced if the starting protein could be made more compatible 
with the target RT site by rational methods. In chapter 3, I used sequence alignment information 
from Cre homologs to find candidate mutations that can change the DNA specificity of Cre. I 
then validated a candidate mutation using Rec-Seq and confirmed the specificity switch. From 
the sequence alignment, I could build a database of mutations and their corresponding changes of 
RT site specificities.  
Rec-Seq could also improve selection of site for cassette exchange in the human genome. 
In Chapter 3, I used Rec-Seq to identify the specificity of recombinases at each position of the 
RT sequence. The combination of knowing the positions on the RT sequence that are difficult to 
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alter and the database of specificity altering mutations can guide the selection of which DNA 
elements within a given genomic interval are the best candidates to target with a recombinase. As 
a demonstration, we searched the sequences upstream and downstream of Huntington’s disease 
genome locus to do RMCE and found candidate target sites. We identified sites in the regions 
upstream and downstream of the huntingtin locus that we predict could be targeted by the VCre 
and Cre recombinases, respectively.  Early directed evolution results using these recombinases 
suggest that these sites can indeed be targeted. 
Rec-Seq can also serve as a test for when the cycle of directed evolution selections can be 
terminated. Rec-Seq can distinguish recombinases that are specific from those that are 
promiscuous within a given window along the arm region. In reported work, a recombinase that 
was evolved for one sequence exhibited even stronger activity for a different, off-target RT site 
(5). Rec-Seq could catch this lack of desired specificity before extensive efforts are expended in 
cell culture experiments. 
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Supplemental Methods 
Protein purification of Cre recombinase variants.   
Proteins were expressed in BL21(DE3) star cells at 25°C using the autoinduction protocol of 
Studier (1).  The cells were harvested by centrifugation after 48 hours. The cell paste was 
resuspended in 25 mL buffer A (0.7 M NaCl, 50 mM Tris-HCl pH 7.8, 5 mM Imidazole), lysed 
by sonication on ice, and separated from cellular debris by centrifugation. The filtered 
supernatant was applied to a HisTrapTM HP column (Amersham) and washed with 30 mL Buffer 
A. The column was then washed with 20 mL 15% buffer B (0.7 M NaCl, 50 mM Tris-HCl pH 
7.8, 500 mM Imidazole). Cre was eluted with a linear gradient from 15% buffer B to 100% 
buffer B, with the elution peak starting at roughly 20% buffer B. Approximately 10 mL of the 
eluted protein was collected and dialyzed overnight at 4°C against 5 L dialysis buffer (0.7 M 
NaCl, 50 mM Tris-HCl pH 7.8). The protein concentration was then determined by UV 
absorbance using an extinction coefficient at 280nm of 49 mM-1cm-1. The protein retained 
activity for months when stored at 4° C. 
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  Replicate 
  1st 2nd 3rd 
total # of cells sorted 
           
7000 7000 7000 
Cre‐A1 hbb 414 378 391 hbb+cmv 3852 3528 3687 
hbb+sp1 3750 3419 3501 
Cre‐B1 hbb 97 102 85 hbb+cmv 1237 1258 1120 
hbb+sp1 1150 1080 1202 
A1+B1 hbb 1117 1212 1324 hbb+cmv 5866 6029 6358 
hbb+sp1 5702 6121 5987 
Cre‐A2 hbb 47 52 41 hbb+cmv 1127 1116 1052 
hbb+sp1 1053 1002 1119 
Cre‐B2 hbb 0 0 1 hbb+cmv 2 2 4 
hbb+sp1 2 1 3 
A2+B2 hbb 573 528 607 hbb+cmv 3180 3409 3698 
hbb+sp1 3221 3336 3593 
Cre‐A3 hbb 0 0 1 hbb+cmv 0 1 1 
hbb+sp1 1 0 0 
A3+B2 hbb 256 233 284 hbb+cmv 1598 1652 1701 
hbb+sp1 1503 1527 1606 
WT hbb 372 391 408 hbb+cmv 3914 4223 4312 
hbb+sp1 3815 3799 4021 
 
Supplemental Table 2.1.  Cell sorting data from mouse ES cells 
Plasmids with the hbb minimal promoter alone or with either the cmv and sp1 enhancers driving 
different cre variants were co-transfected into Ai14 mouse embryonic stem (ES) cells containing 
a reporter cassette with tdTomato preceded by a floxed stop codon. The same total amount of 
DNA was used for all transfections, and 3 independent transfections were performed for each 
Cre variant. The number of tdTomato positive cells was measured by flow cytometry.  
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Supplemental Figure 2.1  
(A) In vitro assay results for Cre mutant pairs lacking computationally designed mutations. 
Linear DNA substrate (0.7 kb) with direct loxP repeats was incubated with Cre mutants. Lane 1: 
Cre-E123L/E308R; lane 2: Cre-E123L/R337E; lane 3: A 1:1 mixture of above two Cre mutants.  
The E123L/E308R mutations are insufficient to eliminate activity in this monomer, indicating 
that additional mutations are necessary to achieve the goal of obligate heterotetramers.  (B) In 
vitro assay results for Cre proteins with wild-type monomer-monomer interfaces. Wild-type Cre 
and Cre-C2#4 were assayed for recombination activity against six loxP/M7 hybrid RT sites. The 
left panel: wild-type Cre recombined robustly on all six RT sites except for all M7 site. The right 
panel: Cre-C2#4 recombined all six RT sites, although with diminished activity with increased 
number of loxP half-sites. 
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Supplemental Figure 2.2.  
Representative raw data from flow sorting experiments. Each point shows the fluorescence in the 
red channel (tdTomato) versus green channel (FITC).  The cell-only and dummy plasmid 
experiments exhibit roughly identical autofluorescence.  The gating for identifying RFP-positive 
is the region of each plot labeled ‘P4’. 
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 Protein Left Target Right Target(reverse complement) NaCl(mM) Result 
1 CreWT LoxP-LoxP NNNNNNNNNNNNN GCATACAT TATACGAAGTTAT 120 No recombination 
2 CreWT LoxP-LoxP NNNNNNNNNTATA GCATACAT TATATAGAGTTAT 120 Figure 3.2A 
3 CreWT LoxP-LoxP NNNNNNNNNTATA GCATACAT TATATAGAGTTAT 170 Figure 3.2B 
4 CreWT LoxP-LoxP NNNNNNNNNTATA GCATACAT TATATAGAGTTAT 200 Figure 3.2C 
5 CreWT LoxP-LoxP NNNNNNNNNTATA GCATACAT TATATAGAGTTAT 210 Figure 3.2D 
6 CreWT LoxP-LoxP NNNNNNNNNTATA GCATACAT TATATAGAGTTAT 220 No recombination 
7 CreWT LoxP-LoxP NNNNNNNNNTATA GCATACAT TATACGAAGTTAT 460 Supplemental figure 3.1A 
8 CreWT LoxP-loxM7 NNNNNNNNNTATA GCATACAT TATACGAAGTTAT 420 Supplemental figure 3.1B 
9 CreWT LoxP-LoxP NNNNNNTCGTATA GCATACAT TATACGAAGTTAT 490 Figure 3.3 
10 CreWT LoxP-LoxP ATAANNNNNNATA GCATACAT TATACGAAGTTAT 490 Figure 3.3 
11 CreWT LoxP-LoxP ATAACTTNNNNNN GCATACAT TATACGAAGTTAT 120 No recombination 
12 CreWT LoxP-LoxP ATAACTTCNNNNN GCATACAT TATACGAAGTTAT 470 Figure 3.3 
13 CreWT LoxP-LoxP ATAACTTCGNNNN NCATACAT TATACGAAGTTAT 500 Supplemental figure 3.1D 
14 CreWT LoxP-LoxP ATAACTTCGTATN NNNNACAT TATACGAAGTTAT 120 No recombination 
15 CreC2#4 LoxM7-LoxM7 NNNNNNNNNTATA GCATACAT TATATAGAGTTAT 370 Non-specific 
16 CreC2#4 LoxM7-LoxM7 NNNNNNNNNTATA GCATACAT TATACGAAGTTAT 340 Non-specific 
17 CreC2#4 LoxM7-LoxM7 NNNNNNCTATATA GCATACAT TATATAGAGTTAT 370 Figure 3.5 
18 CreC2#4 LoxM7-LoxM7 ATAANNNNNNATA GCATACAT TATATAGAGTTAT 420 Figure 3.5 
19 CreC2#4 LoxM7-LoxM7 ATAACTCTNNNNN GCATACAT TATATAGAGTTAT 280 Figure 3.5 
20 Cre259P LoxTA-LoxTA ATAACNNNNNNTA GCATACAT TATATAAAGTTAT 120 No recombination 
21 Cre259P LoxTA-LoxTA ATAACTNNNNATA GCATACAT TATATAAAGTTAT 120 Figure 3.7D 
22 VCre Vlox-Vlox NNNNNNNNNGAGA ACTGTCAT TCTCGGAAATTGA 300 Supplemental figure 3.1C 
23 VCre Vlox-Vlox NNNNNNTCTGAGA ACTGTCAT TCTCGGAAATTGA 300 Figure 3.4 
24 VCre Vlox-Vlox TCAANNNNNNAGA ACTGTCAT TCTCGGAAATTGA 300 Figure 3.4 
25 VCre Vlox-Vlox TCAATTTCNNNNN ACTGTCAT TCTCGGAAATTGA 300 Figure 3.4 
26 VCre Vlox-Vlox TCAATTTCNNNGA NCTGTCAT TCTCGGAAATTGA 70 No recombination 
Supplemental Table 3.1 Summary of recombination experiments.  
Each line corresponds to a single recombination experiment, as described in Figure 1 of 
the manuscript. The first column indicates the recombinase or recombinase mutant used in the 
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experiment. The second column gives the sequence of the (constant) recombinase target (RT) 
site on the ‘left-hand’ side of the DNA substrate, where each half-site of the RT sequence is 
indicated, as in some cases an asymmetric RT sequence was used. The third column gives the 
sequence of the ‘right-hand’ RT site on the substrate, with randomized positions denoted by ‘N’. 
The fourth column indicates the salt concentration used in the experiment. The fifth column 
indicates the result of the experiment. ‘No recombination’ denotes experiments where no 
recombinant product was observed. ‘Non-specific’ denotes experiments without a clear product 
of the expected size. Otherwise, the figure that presents the results of successful experiments is 
reported. 
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Supplemental figure 3.1 Extended library assays for the Cre and VCre recombinases.  
(A)-(C) Results from recombination specificity assays with high complexity libraries that 
randomize the outer nine bases of the RT sequence are presented. (A) Results for wild-type Cre 
recombinase with the indicated DNA substrate, in which all non-random half-sites were the loxP 
sequence. (B) Results for wild-type Cre recombinase where one of the half-sites consisted of the 
loxM7 sequence. (C) Results for the VCre recombinase where all non-random half-sites are the 
cognate VloxP sequence.  
(D) Results from wild-type Cre specificity assays that randomizes four bases in the arm 
region and one base in the spacer region of the RT sequence are presented. All non-random half-
sites are the loxP sequence.  
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Primers for library generation (See Supplemental Table 1 for RT site 
sequence) 
Library-forward 
cccgcgaaattaatacgactcactatagggg-RT-site-ccaattgtccatattgcatcagac 
Library-reverse 
gggttatgctagttattgctcagcggtggcag-RT-site-with-randomized-
library–caacagataaaacgaaaggcccag 
Primers for Illumina sequencing preparation 
Selected-sequencing-forward 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTcccgcg
aaattaatacgactcactatagggg 
Sequencing-reverse 
CAAGCAGAAGACGGCATACGAGAT-index-
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgggttatgctagttattgctcag 
Unselected-sequencing-forward 
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTgccgta
gcgccgatggtagtgtggggtctccc 
